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ABSTRACT 
Pre-mRNA splicing requires interaction of cis- acting intron sequences with trans -acting 
factors: proteins and small nuclear ribonucleoproteins (snRNPs). The assembly of these 
factors into a large complex, the spliceosome, is essential for the subsequent two step 
splicing reaction. First, the 5' splice site is cleaved and free exon 1 and a lariat intermediate 
(intron- exon2) form. In the second reaction the 3' splice site is cleaved the exons ligated 
and lariat intron released. A combination of genetic and biochemical techniques have been 
used here to study pre-mRNA splicing in yeast. 
Yeast introns have three highly conserved elements. We made point mutations 
within these elements and found that most of them affect splicing efficiency in vivo and in 
vitro, usually by inhibiting spliceosome assembly. 
To study trans -acting splicing factors we generated and screened a bank of temper-
ature-sensitive (ts) mutants. Eleven new complementation groups (prp17 to prp27) were 
isolated. The four phenotypic classes obtained affect different steps in splicing and accu-
mulate either: 1) pre-mRNA, 2) lariat intermediate, 3) excised intron or 4) both pre-mRNA 
and intron. The latter three classes represent novel phenotypes. The excised intron ob-
served in one mutant: prp26 is stabilized due to protection in a snRNP containing particle. 
Extracts from another mutant: prpl8 are heat labile and accumulate lariat intermediate and 
exon 1. This is especially interesting as it allows analysis of the second splicing reaction. 
In vitro complementation of inactivated prp18 extracts does not require intact snRNPs. 
These studies have also shown the mutation to be in a previously unknown splicing pro-
tein. A specific requirement for A TP is also observed for the second step of splicing. The 
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The removal of introns, from the primary transcript occurs by RNA splicing. Three major 
types of RNAs ( tRNA, rRNA and mRNA) are known to contain introns. There are two 
general questions concerning any splicing mechanism: first, how is the precise recognition 
and alignment of the splice junctions achieved in introns whose lengths vary from a few 
hundred nucleotides to several thousands of nucleotides, and second, what are the bio-
chemical mechanisms of the cleavage and ligation reactions. 
The specificity of the splice junction selection and the juxtaposition of the exons is 
achieved in Group I introns (e.g.,Tetrahymena rRNA, some yeast mitochondrial introns, 
choloroplast tRNA introns) and Group II introns (e.g. fungal mitochondrial introns) by the 
conserved secondary and tertiary structure of the intron . In group I splicing, the intron is 
excised in a RNA catalysed reaction. The catalytic RNA is the intron itself and splicing oc-
curs in the presence of a guanosine cofactor. Splicing of Group II introns have also been 
shown to take place by self excision, and the excised intron is released as a branched lariat 
RNA, a structure also produced in nuclear pre-mRNA splicing ( reviewed by Cech and 
Bass 1986). 
The splice site selection in nuclear pre-mRNA is dictated only by short stretches of 
sequences at or near the splice junctions (Shapiro and Senapathy 1987). Splicing involves 
interaction of these cis-acting sequences with many cellular factors including proteins and 
small nuclear ribonucleoproteins (snRNPs) (reviewed in Sharp 1987 ; Maniatis and Reed 
1987). The development of in vitro splicing systems from mammalian cell lines and from 
the yeast, Saccharomyces cerevisiae , has revealed a two step splicing reaction scheme for 
splicing (Fig.1a). First, cleavage at the 5' splice junction results in the formation of a lariat 
intermediate of intron-exon2 in which the first base of the intron is covalently linked by a 
2'-5' phosphodiester bond to an internal adenosine near the 3' splice site. In the second 
step, the 3' splice junction is cleaved and the exons are ligated to give the mRNA and the 
lariat intron. Mechanistically, the reaction scheme is very similar to that of the self-splicing 
Group II introns; however, the nuclear pre-mRNA splicing machinery is more complex. In 
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splicing reactions studied in vitro the pre-mRNA and the splicing intermediates are associ-
ated with a large complex, termed the spliceosome (Brody and Abelson 1985; Grabowski 
et al., 1985; Frendewey and Keller 1985). The spliceosome resembles the complexity of 
ribosomal subunits in that it consists of several RNAs and proteins. It is also clear now 
that at least five snRNPs (U1, U2, U4, U5 and U6), are required for splicing in both yeast 
and mammalian systems. The participation of at least one heterogeneous nuclear ribonu-
clear protein (hnRNP) is also indicated in pre-mRNA splicing. 
Enumeration, identification and determination of the function of spliceosomal com-
ponents are essential for the complete understanding of the splicing machinery and its 
operation. Biochemical fractionation of extracts derived from several organisms has pro-
vided a useful approach in such an analysis. The extensive genetic repertoire of the yeast 
Saccharomyces cerevisiae allows the isolation and the characterization of mutants in the 
splicing pathway. The analysis of such mutants and the isolation of the wild type gene 
product of these loci is a powerful ally of the biochemical studies. A combined genetic and 
biochemical approach has therefore been taken by several groups working with yeast, in 
their attempt to identify the factors involved in the assembly and function of the spliceo-
some. 
ROLE OF CIS ACTING SEQUENCES 
The sequences in the pre-mRNA recognized for the formation of the spliceosome are found 
near the boundaries of the intron. In higher euk:aryotic pre-mRNA the introns are bounded 
at the 5' splice site by a consensus sequence of about eight nucleotides and at the 3' splice 
site by a poly pyrimidine (Py) stretch followed by an AG. The intron sequences utilized 
for the formation of the branch are variable, but the branch acceptor nucleotide is generally 
an A (reviewed in Padgett eta/., 1986 ; Green 1986). Considerable variation of these 
conserved elements is observed in metazoan introns. Correct splice site selection in meta-
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zoan introns therefore requires discrimination between bonafide splice sites and the many 
sequences that resemble the splice sites. 
The situation is different in yeast, where analyses of intron sequences have revealed 
three highly conserved elements required for splicing. These are the 5' consensus 
GUAPyGU, the 3' junction sequence PyAG, and the internal UACUAAC near the 3' 
splice site. The acceptor nucleotide for branch formation in lariats is the penultimate nu-
cleotide of the highly conserved UACUAAC sequence (Domdey eta/., 1984; Rodriguez et 
al., 1984). These elements delineate the intron borders in most yeast genes. Analysis of 
mutations in these sequences have demonstrated the importance, and in some cases the ne-
cessity, of these conserved residues for pre-mRNA splicing. Most mutations in these con-
served intron sequences affect the reactions of splicing, lariat intermediate formation and 
exon ligation, to varying degrees. In contrast, mutations in the splice sites of higher eu-
karyotes usually result in the activation of cryptic splice sites. 
At the 5' splice site, mutations in the 5' G or U allow the first step of splicing to 
proceed, thereby allowing the lariat intermediate formation, but not the second reaction of 
splicing (Newman et al., 1985 ; Fouser and Friesen 1986 ; Vijayraghavan et al., 1986). 
Activation of cryptic 5' splice sites, rarely seen in yeast splicing systems, occurs upon mu-
tation of the fifth nucleotide in GUAPyGU to a A or C (Parker eta!., 1985 ; Fouser and 
Friesen 1986). Hence, the GU dinucleotide does not seem to be essential for the precise 
cleavage, but the fifth nucleotide plays a role in the precision of the 5' splice site selection. 
These 5' splice site mutations which cause cryptic splice site utilization, result in the 
formation of dead end lariat structures. 
Mutations in most nucleotides of the branch acceptor sequence inhibit the first step 
of the splicing, leading to accumulation of pre-mRNA. Mutations at the highly conserved 
branch acceptor nucleotide, A, do not alter the site of branch point formation. When the 
branch acceptor nucleotides is a C, inefficient splicing is observed ( Fouser and Friesen 
1986; Vijayraghavan et al., 1986). However, G functions as a better branch acceptor than 
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C, but completely inhibits the second reaction of splicing (Fouser and Friesen 1986). 
These results suggest that the structures of the branch site play a significant role in the sec-
ond reaction of splicing. 
Unlike metazoan introns, the 3' splice site in yeast is determined only by the PyAG 
sequence and no equivalent of the polypyrimidine stretch is found. The 3' splice site 
mutations do not affect the first step of splicing, suggesting that they play little role in the 
early events of splicing. In fact, sequences downstream of the UACUAAC sequence and 
the 3' splice site do not seem to be required for the first step of splicing (Cellini et al., 1986 
; Rymond and Rosbash 1985) in contrast to the critical role played by the polypyrimidine 
stretch in metazoan introns (Wieringa eta/. , 1984; Frendewey and Keller 1985). Point 
mutation in the conserved AG sequence of yeast intron affects only the second step of the 
splicing reactions (Vijayraghavan eta/., 1986). These results indicate that, in general, the 
sequence elements in yeast and metazoan introns function in slightly different ways. The 
requirements in yeast for lariat intermediate formation are the presence of a proper 5' splice 
junction and a branch acceptor site. Sequences downstream of the UACUAAC are notre-
quired for lariat formation, but a minimal RNA length downstream of the UACUAAC se-
quence is required for the first step of splicing (Rymond eta/., 1987). The second step of 
splicing requires a PyAG 7 to 55 nucleotides downstream of a suitable branch structure. 
Intron sequences besides the conserved elements play a role in affecting the efficiency of 
splicing in vivo (Pikielny and Rosbash 1985). 
YEAST SPLICEOSOMAL snRNA 
Studies on the snRNAs (small nuclear ribonucleic acids) from metazoans have focussed on 
the abundant ones (namely U1 through U6 RNAs), which range in size between 90 and 
216 nucleotides (nts). These snRNAs are usually found in the form of ribonucleoprotein 
complexes (snRNPs). Each of these U class snRNPs generally consists of a single RNA 
complexed with about six to ten proteins. The Ul to U6 snRNPs all belong to the Sm 
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class, which contain a highly conserved set of proteins recognised by a set of human auto-
immune antibodies. The Sm antigen is believed to bind to a consensus AU4-6 G motif in 
a single stranded region of the RNA. The U4 and U6 snRNAs are complexed in the same 
snRNP. The association between the U4 and U6 RNAs is due to base pairing interaction 
between the two RNAs. Oligonucleotide-directed RNase H cleavage of U1 , U2, U4, or 
U6 inhibits splicing reactions in vitro , implying a role for these snRNAs in splicing 
(reviewed in Maniatis and Reed 1987). Based on ribonuclease protection experiments, U1 
binds the 5' splice site and U2 to the branch formation site. These experiments also sug-
gest that a snRNP, possibly U5, recognises 3' splice site. No specific binding site for the 
U41U6 snRNP has been identified yet. The hypothesis of pre-mRNA-U1 interaction 
through base pairing was first suggested on the basis of sequence complementarity between 
the 5' terminal nucleotides of U1 and the 5' splice site (Lerner et al., 1980 ; Rogers and 
Wall 1980). This model has genetic support as splicing of 5' splice site defective pre-
mRNA can be restored by compensatory base mutations in the U1 RNA (Zhuang and 
Weiner 1986). 
A search for snRNAs in yeast by the criterion of the presence of the characteristic 
trimethyl cap structures has identified a set of at least 24 snRNAs that show a great varia-
tion in size from 100 to 1200 nt (Riedel et al., 1986). The striking differences from the 
well characterised metazoan U class snRNAs are their low abundance of only 10-1000 
copies per cell and the fact that they are encoded by single copy genes. Several of the ini-
tially analysed snRNAs of yeast were non-essential and these results were unexpected and 
made it difficult to establish a link between pre-mRNA splicing and snRNA in yeast . 
Some of snRNA genes (called SNR) have now been found to be essential for 
growth; they include SNR7, SNR14, SNR19, SNR20, and SNR6 (reviewed in Guthrie 
and Patterson 1988). By a variety of other criteria this very same subset of essential 
snRNA was thought to be spliceosomal snRNAs. The structure of the first yeast U analog 
(U2 snRNA), proved to be a surprise due to the fact that it was six times larger than its 
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mammalian counterpart-- 1175 versus 189 nts (Ares 1986). Extensive homology at the 5' 
terminus of the yeast U2 RNA was found to the mammalian U2 snRNA. In addition to the 
homology to the mammalian U2, the yeast U2 also has internal domains with homology to 
mammalian U4, U5, and U6 snRNA. The theory that these domains could make this long 
snRNA from yeast a poly-snRNA equivalent, no longer holds for two reasons. Deletions 
removing large portions of the U2 snRNA are viable, and indispensable equivalents to the 
U4, U5, U6 snRNA have been found in yeast. Strains containing deletions that remove all 
but the domain with U2 homology and a stretch of -lOOnts at the 3' end of the yeast U2 
snRNA gene are viable (E. Shuster and C. Guthrie, pers. comm.). This leaves the func-
tional domain as the region with homology to U2. Cloning and sequencing of other yeast 
spliceosomal snRNA indicates that yeast snRNAs in general tend to be larger than their 
mammalian equivalents. 
The question of whether recognition by the U2 snRNP of the branch point se-
quence is due to base pairing has been tested genetically in yeast (Parker eta!., 1987). 
Supressor mutations in the SNR20 gene (which codes for the yeast U2 snRNA) were made 
to two point mutations in the UACUAAC actin intron sequence. The presence of the U2 
supressor plasmid in a strain with mutant UACUAAC sequence integrated in the chromo-
some shows complete supression of both the growth and the splicing pattern. The supres-
sion was allele specific. The base pairing interaction between nucleotide near the 5' end of 
U2 and the branch sequence of yeast introns requires bulging out of one of the two adeno-
sine nucleotides at the 3' end of UACUAAC. It has been suggested that the branch nu-
cleotide be bulged out (Fig 2). This achieves the maximum number of base pairing 
interactions between the two RNAs and this also provides a similarity to the autocatalytic 
Groupll introns, where the lariat formation occurs at a bulged out A of a conserved ele-
ment. 
Secondary structure analysis has been able to define an essential yeast homolog to 
the mammalian U5 snRNA (Patterson and Guthrie 1987). This homology is found in a 70 
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nt domain with limited sequence homology but striking structural homology to the higher 
eukaryotic US snRNAs. Construction of a SNR7 gene under the control of an inducible 
promoter has allowed analysis of the biochemical phenotype when US snRNA is depleted 
in the cell. Accumulation of unspliced pre-mRNAs is seen after five generations of shift to 
uninduced conditions, demonstrating that US is essential for splicing. 
Yeast U4, which is also Sm precipitable, is 160nt long and has several stretches of 
similarity to mammalian U4 and a similar secondary stucture (Siliciano et al., 1987). The 
most striking conservation is in the S' half of the molecule. Native gel electrophoresis of 
the snRNA from yeast has revealed an interaction of U4 with a second RNA designated 
U6. This RNA has primary sequence homology to U6 from humans and other organisms 
and is the most highly conserved spliceosomal snRNA. The U4 and U6 of yeast are asso-
ciated in a complex with a melting temperature of S3C, suggesting extensive base pairing 
between the two RNAs (Brow and Guthrie 1988). This stable association indicates that an 
active mechanism must exist for the destabilization of the U4/U6 that is observed in in vitro 
splicing reactions (discussed in a later section). 
The yeast U1 analogue although much longer than U1, has several regions of ho-
mology to Ul. The 10 nucleotides at the S' end are completely conserved when compared 
with the S' end of U1 snRNA (Kretzner et al., 1987 ; Siliciano et al., 1987). This strict 
sequence conservation between the U1snRNAs implies the generation of a one base mis-
match between yeast Ul and the almost invariant GUAPyGU at the S'splice site of yeast 
introns (Fig 2). Base pairing contributions between U1 and the S' splice site had already 
been shown in mammalian systems (Aebi et al., 1987; Zhuang and Weiner 1987). Similar 
models have been tested in yeast, and these results are particularly interesting in the light of 
the unexpected lack of complete complementarity between the S' splice site and the U1 
snRNA. Recent evidence has demonstrated base pairing in at least two positions. In con-
trast to mammalian systems, precision at the S'splice site is not determined solely by base 
pairing interactions with the Ul snRNP (P. Siliciano and C. Guthrie, per. comm.). 
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THE SPLICEOSOME AND ITS ASSEMBLY 
The bimolecular structure (lariat intermediate and exon 1) of the intermediates of pre-mRNA 
splicing strongly suggest the existence of a multicomponent structure on which pre-mRNA 
splicing takes place. Such a complex would hold together the two RNAs for the second 
step of the process. Splicing complexes were first detected upon sedimentation of in vitro 
reactions in glycerol gradients, whereupon a co-sedimentation of the splicing intermediates 
in a 40-60S particle was observed. This particle was named the spliceosome. The forma-
tion of the spliceosome was found to be necessary for the splicing reaction, and its assem-
bly requires the presence of appropriate 5' splice site and 3' splice site sequences in mam-
malian systems; and in yeast, of the 5' and the UACUAAC sequences. A requirement for 
A TP was also observed in both systems in vitro (Brody and Abelson 1985 ; Grabowski et 
al., 1985; Frendewey and Keller 1985; Vijayraghavan et al., 1986). Depletion or inacti-
vation of hnRNP proteins (Choi et al., 1986) or snRNPs from the HeLa extracts ( Fren-
dewey and Keller 1985; Grabowski et al., 1985) abolishes the formation of this complex. 
A higher resolution of separation of the assembly intermediates and the spliceosome 
than that obtained on glycerol gradients was achieved by running splicing complexes on 
non-denaturing polyacrylamide gels. Heparin or total RNA was added to remove non-spe-
cific aggregation to the splicing complexes. The studies with yeast and mammalian in vitro 
reactions on these gel systems demonstrated the presence of three splicing-dependent, ki-
netically ordered complexes (Konarska and Sharp 1986 ; Pikielny et al., 1986). An early 
complex of U2 and pre-mRNA whose formation is A TP dependent is followed by the ap-
pearence of a complex with U2, U4, U5, and U6 containing the pre-mRNA. The splicing 
intermediates were found in the third complex, which surprisingly did not have any U4, 
indicating a destabilization and exit of the U4 from the U4/U6 snRNP complex and the 
spliceosome. It was thus unclear if the U4 snRNA leaves the spliceosome before, after or 
during the first step of the splicing reaction. A fourth splicing complex containing U2, U4, 
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U6, US (complex A2-1 in Fig 1 b and Fig 3) and only the pre-mRNA was subsequently 
found (Cheng and Abelson 1987 ; Lamond eta/., 1988). The detection of this complex 
demonstrated that before the formation of an active spliceosome, U4 snRNP left the splic-
ing complexes. The complex containing the splicing intermediates (active spliceosome) 
was kinetically the last to form. Similar to the results from mammalian systems the Ul 
snRNP was not detected in any of these non denaturing gel complexes. Of the products of 
the reactions, the lariat intron is associated with a complex of US, U6 and U2 snRNPs in 
nondenaturing gels of splicing reactions with Hela extracts (Konarska and Sharp 1987). 
The other product, the mRNA, is not associated with any snRNP but is probably associ-
ated with some hnRNPs and is transported to the cytoplasm. 
The formation of the kinetically early assembly intermediate of pre-mRNA and U2 
snRNP requires the addition of A TP. In HeLa cell extracts the U2 binding requires both 
the polypyrimidine and the 3'AG (Ruskin and Green 198S). Analysis of double mutants 
with sequence alterations in both the 5' and the 3' splice sites of mammalian introns reveals 
that an interaction between the 5' and the 3' splice site promotes formation of the U2 con-
taining complex (Lamond et a/., 1987). Mutations in the yeast 5' splice site or the 
UACUAAC that cause accumulation of pre-mRNA in splicing reactions, prevent even the 
binding of U2 snRNP (Cheng and Abelson 1987). The length of the pre-mRNA per se 
influences later stages of the spliceosome assembly (Rymond eta/., 1987). Substrates 
with short RNA stretches after the branch consensus sequence fail to undergo even the first 
reaction of splicing. Accumulation of early complexes containing only the pre-mRNA is 
seen, indicating that the failure to form lariats is due to a specific assembly defect. Muta-
tions in the yeast 3' splice site consensus sequences that allow lariat intermediate 
accumulation in splicing reactions accumulate the late spliceosome with U2, U5, and U6 
(Cheng and Abelson 1987). A more recent study on the effect of chemical modification 
and interference pattern of the pre-mRNA on the assembly and maturation of spliceosomes 
and on the splicing reaction has been conducted (Rymond and Rosbash 1988). This study 
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indicates that regions of the pre-mRNA sequence that are essential for splicing include, but 
are not limited to, the conserved intron sequences. 
Analysis of the spliceosomal constituents using affinity chromatography with 
poly A+ pre-mRNA in splicing reactions or with biotinylated pre-mRNA has been done 
(Pikielny and Rosbash 1986; Grabowski and Sharp 1986). The spliceosome can be iso-
lated from reactions, in the former case with oligo-dT cellulose and in the later case with 
strepavidin agarose beads. Affinity chromatography after glycerol gradients sedimentation 
of in vitro splicing reactions has shown an association of U2, U4, U5, and U6 snRNAs 
with the spliceosome. U1 RNA was not seen to be associated under these conditions, in 
spite of its previously demonstrated requirement in splicing. A more detailed analysis of 
splicing complexes purified by affinity chromatography under varying conditions has 
demonstrated the presence of U1 with the pre-mRNA, at least in higher eukaryotic splicing, 
is sensitive to heparin or high salt concentrations (Bindereif and Green 1987). This finding 
explains the failure to detect U1 by affinity chromatography in heparin treated spliceosomes 
isolated from the gradients. The association of the U1 snRNP was shown to be rapid and 
A TP independent, while that of U2, U4, U5, and U6 was A TP dependent. An assembly 
order where U1 binding precedes U2 and U4/U5/U6 binding, has been suggested. 
Recent experiments using affinity chromatography of yeast splicing reactions also 
indicate a very early ATP independent binding of U1to the pre-mRNA. U1 binding de-
pends on both the 5' splice site and branch point sequence, and functional U1 binding is a 
requirement for the subsequent binding of other snRNAs (U2, U4, U5, U6) (S. Ruby and 
J. Abelson, in press). Using a different approach to address the commitment of pre-
mRNA to splicing, Legrain et al., (1988) have shown that an early commitment to splicing 
takes place in extracts which are depleted in U2 snRNP. This commitment also requires 
the presence of active 5' splice site and UACUAAC sequence. 
The snRNP-mediated recognition events in splicing and in the assembly of the ma-
ture spliceosome range from direct base pairing interactions between the snRNA compo-
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nents of the snRNPs and the intron sequences, to interactions co-ordinated solely by pro-
tein factors. The existence of these protein factors has been demonstrated by the need for 
micrococcal nuclease- resistant factors in in vitro splicing and upon purification of splicing 
factors (Krainer and Maniatis 1985; Cheng and Abelson 1986; Kraemer et al., 1987). At 
least one factor identified from HeLa extracts, U2AF (U2 Auxiliary factor) is required for 
binding of U2 to the substrate. U2AF recognizes the 3' splice site, the polypyrimidine I 
AG and is required for the formation of a stable pre-rnRNA-U2 containing complex 
(Ruskin et al., 1988). Another factor, the intron binding protein, that also binds the 3' 
splice site is known. Initial experiments suggest that this protein mediates U5 snRNP in-
teraction with the 3' splice site (Tazi et al., 1986). The suggestion has been made that 
multiple factors interact independently with the 3' splice site during spliceosome assembly 
in mammalian systems. Identification of several protein factors required in yeast splicing 
reactions has been possible through the use of the yeast rna mutants, and will be discussed 
in the next section of this review. 
snRNP-snRNP interactions that mediate the formation of higher order structure are 
still poorly understood. Non-denaturing gels have also been used to detect multiple snRNP 
interactions that take place in the the extract. In fact, complexes containing the snRNAs 
have provided one line of evidence for the existence of snRNP complexes in yeast. In both 
yeast and mammalian systems, U4/U5/U6 snRNA are found to co-exist as a large particle 
(Konarska and Sharp 1987 ; Cheng and Abelson 1987). In yeast this large particle 
dissociates into U5 and U4/U6 complexes upon addition of ATP. During the splicing re-
actions, U4 has been shown to leave the spliceosome before U6 and before the first splic-
ing reaction takes place. Thus the process of assembly and disassembly of snRNPs seems 
to be a dynamic process. The U1 and U2 RNA of yeast are also associated with proteins 
as U1 snRNP and U2 snRNP. However they are not associated in any larger multiple 
snRNP particle. 
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Purification of mammalian spliceosomes after preparative gel filtration has enabled 
visualisation of the spliceosomes by electron microscopy. The spliceosome fractions re-
vealed a population of 40-60nm particles (Reed eta/., 1988). Yeast spliceosomes partially 
purified by differential gradient sedimentation have been identified by EM. Ovoid particles 
of about 20 x 23.5 nm were seen, following tagging with several probes (M. Clark, 
S.Goelz and J.Abelson, manuscript submitted) . 
THE RNA MUTANTS OF YEAST 
Along with the analysis of snRNA, an important aspect in the genetic analysis of splicing 
in yeast has been the availability of several trans-acting mutants that affect pre-mRNA 
splicing. These mutants were identified as temperature sensitive (ts) lethals in the genes 
RNA 2 through RNAJJ in a general search for mutants affecting macromolecular 
biosynthesis in a bank of ts lethals (Hartwell 1967) . Many of these mutants turned out to 
be involved in splicing because of a peculiarity of the yeast genome. The rna2-11 mutants 
showed a rapid cessation of net RNA accumulation upon shifting cultures to non permissive 
temperature. The mutants were subsequently shown to be defective in rRNA synthesis but 
not in tRNA or mRNA synthesis. The defect in rRNA synthesis was not in transcription 
but in the processing of the large pre-rRNA (Warner and Udem 1972). Interestingly, these 
mutations severely decreased the levels of most ribosomal protein mRNAs, and most non-
ribosomal protein mRNAs were not affected. Subsequently a number of laboratories found 
that the genes coding for most ribosomal proteins contain introns. Intron-containing ribo-
somal transcripts accumulate at non- permissive temperature in these strains, while non in-
tron-containing transcripts were unaffected (Rosbash et al., 1981). These data finally sug-
gested that the defects in rRNA processing were due to defects in the splicing of precursors 
to ribosomal protein mRNAs. The apparent specificity of the defect was due to the pre-
ponderance of introns in genes coding for ribosomal proteins and the rarity of introns in 
non-ribosomal protein genes. Accumulation of pre-mRNA in other intron-containing yeast 
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transcripts for e.g. actin has also been observed (Teem et al., 1983). Although the defi-
ciency in splicing of the rna mutants does not prove that they encode a part of the pre-
mRNA splicing apparatus, these mutants were the best candidates for the genetic analysis 
of the components of the yeast nuclear splicing machinery (Warner 1987). 
Evidence for the direct participation of many of the RNA 2-11 gene products in the 
splicing reaction came from in vitro biochemical work (Lustig eta/. , 1986). This was 
made possible by the use of a heat inactivation assay with the in vitro splicing system. 
Splicing activity in extracts from rna strains are heat sensitive in vitro . Seven of the nine 
complementation groups tested were heat inactivated. This loss of activity in different rna 
mutants was due to the inactivation of an exchangeable component as shown by in vitro 
complementation of pairs of inactivated extracts. 
The RNA 3, 5, 7, 8, and 11 gene products are required early in the splicing path-
way (Lin eta/. , 1987) as heat inactivated extracts do not form splicesomes (Fig 3). The rna 
4 extract does form an early splicing assembly intermediate (complex B, Fig 3) after heat 
inactivation (J. Banroques and J. Abelson, unpublished results). The reason for involve-
ment of many of the RNA gene products early in the splicing pathway is not understood. 
Oqe reason could be that a large number of factors are required early in spliceosorne as-
sembly, or that there are shared components between the different steps of splicing. The 
RNA2 gene product acts after spliceosome assembly, as heat inactivated rna2 extracts ac-
cumulate spliceosomes (Lin et al., 1987; Cheng and Abelson 1987). In the splicing path-
way this splicing complex immediately preceeds the reactive spliceosome (AI, Fig1b and 
Fig 3). Spliceosomes formed in heat inactivated rna2 extracts are active intermediates in the 
splicing pathway, and, when isolated from glycerol gradients, the accumulated pre-mRNA 
can be chased to products. These experiments indicated that RNA2 is an extrinsic compo-
nent of the spliceosome. These experiments also support the presence of at least two other 
sets of extrinsic factors, bn and Cn required for the first and second reactions of splicing, 
' 
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respectively. Factor bn has been shown to be a micrococcal nuclease resistant, heat stable 
protein(s) required with RNA2 for the first step of splicing. 
Several of these RNA genes (RNA 2, 3, 4, 5, 8 and 11) have been cloned and their 
molecular characterisation has been initiated. The characteristics are summarised in Table 
1. The role that these genes play in pre-mRNA splicing is being investigated by the use of 
antibodies directed against the proteins. The antisera raised against RNA2 , RNA3 and 
RNAJJ products have been used to localize these proteins to the nuclei (Last and Woolford 
1986 ; Chang eta/., 1988). In the case of RNA 11, immunoelectron microscopy has placed 
the protein in the periphery of the yeast nucleus. 
Antibodies against RNA8-B gal fusions have identified the protein as an exception-
ally large 260 Kilodalton (kD) protein . A role for RNA8 in the splicing pathway has been 
shown, with experiments demonstrating loss of splicing activity after immunodepletion of 
RNA8 (Jackson eta/., 1988). The RNA8 antibodies have been used to probe for a stable 
association of this protein with the yeast snRNAs. These antibodies can specifically pre-
cipitate U5 from yeast extracts indicating an association of the RNA8 protein and 
U5snRNA (Lossky eta/., 1987). Preincubation of extracts with A TP resulted in immuno-
precipitation of U6 and U4 along with U5. The co-precipitation of U4/U6 under these 
conditions may result from snRNP-snRNP interactions. 
Recent experiments with RNA4 antibodies reinforce the view of a direct role in 
splicing for the RNA4 protein. There are two principal findings. First the RNA4 antisera 
in immunoprecipitation experiments precipitate yeast U5, U4 and U6 snRNAs. U6 
snRNA is known to exist in a complex of proteins as U6 snRNP and also in a particle with 
U4 snRNA in it. Thus, the co-precipitation of U4 and U6 is not unexpected. Second the 
RNA4 antibodies inhibit in vitro splicing reactions completely. These two results are cor-
roboratory: inhibition of splicing occurs after U2 binds the pre-mRNA (complex B, Fig 3) 
because anti RNA4 antibodies precipitate U4/U5/U6 snRNAs (J. Banroques and J. Abel-
son, unpublished observations). 
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In the case of RNAll, cloned DNA has been transcribed and translated in vitro to 
generate a 35s labeled RNA11 protein (Chang et al., 1988). This labeled protein comple-
ments in vitro the heat sensitivity of rnall extracts. The complementation using the labeled 
protein has allowed tracing of RNAJJ in splicing complexes. In extracts prepared from 
rnall strain most of the protein enters a 30S complex whose formation is not dependent on 
the presence of pre-mRNA. A fraction of the labeled protein does associate with 40S 
spliceosomes; this association is dependent on the presence of splicing signals in the pre-
mRNA. Interestingly, the protein sequence is predicted to have a Zn finger domain, previ-
ously shown to be a motif found in DNA and RNA binding proteins. 
Interactions between the RNA gene products have been indicated both by charac-
terization of extragenic supressors and by experiments showing that increased dosage of 
one RNA gene product can rescue the lethality of another. The first extragenic suppressor 
of rna mutants to be isolated was SRN 1 (Pearson et al., 1982). Mutants in SRN1 were 
isolated on the basis of supressing a rna2 rna6 double mutant . However, SRN1 does not 
display any allele specificity in its supression, as supression of several rna mutants was 
observed. These results indicate that the different mutants are related but does not indicate 
any specific interaction between the RNA gene products. Last et al. (1987) have defined a 
specific interaction between RNA3 and RNA4, as extra plasmid-borne copies of RNA3 can 
rescue the ts lethality of three alleles of rna4 . The supression of rna4 requires the pres-
ence of the mutant rna4 protein, indicating that RNA4 is not being bypassed. An extra-
genic supressor of rna2 (SRN2) has also been obtained. SRN2 supressed six different al-
leles of rna2 but not other rna loci. SRN2 is itself an essential gene. The mode of action 
of SRN2 and RNA3 in supression of rna2 or rna4 respectively can be explained by differ-
ent models. For example : SRN2 and rna 2 are interacting proteins, RNA3 and RNA4 
interact, and the overproduction of one allows stabilization of the other by virtue of the in-
teraction. 
17 
That the RNA3 and RNA4 gene products interact is also suggested by in vitro heat 
inactivation and complementation data where a weaker complementation than that obtained 
for other combinations was found (Lustig et al., 1986). These results suggest that they 
could be part of the same macromolecular complex, a hypothesis consistent with the evi-
dence for the interaction between these gene products. 
ISOLATION OF NEW MUTANTS AFFECTING PRE-mRNA PROCESS-
ING 
As is evident from the discussions of the rna2-11 mutants, the use of such an approach to 
isolation of gene products that play a role in the splicing in yeast has been tremendously 
fruitful. It is possible to isolate more mutants defective in pre-mRNA splicing. One ap-
proach is the generation of temperature or cold-sensitive banks of mutagenised strains, 
which can be screened for pre-mRNA processing defects. Analysis of conditional pheno-
types other than temperature sensitivity would be useful to isolate mutants in some genes 
that do not readily mutate to give ts alleles. 
Our effort to isolate newts lethals, defining genes involved in pre-mRNA has re-
sulted in the identification of several new complementation groups (U. Vijayraghavan and 
J. Abelson, manuscript in preparation). Five new complementation groups with three 
novel phenotypes not seen in the rna2 to rnall mutants were isolated: in one case accu-
mulation of lariat intermediate of splicing was observed and in another case accumulation of 
the released intron was seen, and in the third case an accumulation of both pre-mRNA and 
intron was observed. The isolation of a ts mutations causing accumulation of the lariat in-
termediate provides a unique opportunity to study the components needed for the second 
step of splicing, cleavage at the 3' splice site and the ligation of exons. In vitro splicing 
using extracts prepared from one of these mutant strains can be heat inactivated, and inacti-
vation results in accumulation of the lariat intermediate and ex on 1. Intact snRNPs are not 
required for complementation as micrococcal nuclease treated extracts complement inacti-
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vated extracts. Spliceosomes formed after heat inactivation contain an expected lariat in-
termediate and exon 1. These intermediates can be chased to products upon addition of 
complementing fractions to the assembled mutant spliceosome. These chasing experiments 
have also defined a requirement for A TP in the second step of the splicing reaction. 
The accumulation of the intron in one complementation group does not confer a 
temperature sensitive phenotype, and the isolation of the mutant as a ts was serendipitous. 
The cellular intron in this mutant exists in a large particle of about 40S in extracts prepared 
from mutant strains. Co-sedimentation of snRNPs with the intron-containing particle sug-
gests an association of the intron with the snRNPs. Tri-methyl G cap and Sm specific an-
tibodies that precipitate snRNPs, also precipitate intron from whole cell extracts, support-
ing the view that the intron is associated with snRNPs. The accumulation of the intron 
could be due to the defect in a lariat debranching function, or due to a defect in the disas-
sembly of the intron-containing particle after splicing has been completed. 
A different approach to isolation of mutants in gene products involved in splicing is 
applicable to yeast for the study of macromolecular complexes. This is the isolation of ex-
tragenic supressors tots mutants in the rna2-11 groups. These supressors could define in-
teracting gene products, which are themselves a part of the splicing machinery. In such an 
approach several pseudo-revertants to rna4 that allow growth at a temperature that is non-
permissive have been obtained. These pseudo-revertants (srn4 ) themselves confer a cold-
sensitive phenotype to the cell and segregate as single nuclear recessive genes (J. Maddock 
and J. Woolford, per. comm.). None of these pseudo-revertants of rna 4 are allelic to 
known rna genes. srn4-1, and srn4-2 supress rna4 on the basis of their isolation and also 
supress rna3 . RNA4 and RNA3 have previously been shown to interact and the isolation 
of a supressor to both is not surprising. The supressors do not work by substituting for 
the RNA4 or the RNA3 function as supression by srn4 does not work with null alleles of 
RNA4 or RNA3. srn4-1 and srn4-2 are candidates for mutations in genes whose prod-
ucts directly interact with these RNA genes. The use of cold-sensitive supressors of ts 
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mutations should bring the system around to a complete circle genetically, with mutants in 
genes for some components supressing ts mutants in genes for other components. Such 
analysis would also be extremely useful to map out interactions between these gene prod-
ucts. 
A parallel genetic approach for identifying the components of the splicing machin-
ery is the isolation of trans-acting supressors to point mutants in the pre-mRNA splicing 
signals that are essential for splicing. A trans-acting supressor, that restores splicing of a 
branch point mutation in a yeast intron has been isolated (Couto et al., 1987). This allele-
specific supressor behaves as a single Mendelian gene, with a dominant supression phe-
notype. A recessive effect of accumulation of unspliced wild type pre-mRNA was also 
observed. These two phenotypes argue for a direct role for the RNA16locus in the splic-
ing machinery. A similar approach to isolate supressors to point mutations in essential re-
gions of spliceosomal snRNAs, should allow defmition of components of snRNPs. 
The isolation of trans-acting conditional mutants affecting pre-mRNA splicing, the 
isolation of supressors to these mutants and the isolation of supressors to mutants in the 
pre-mRNA should define many gene products of the splicing apparatus. The analysis of 
the effects of conditional mutants biochemically should be possible when extracts prepared 
from these strains are inactivated in vitro. Inactivation and complementation of these ex-
tracts would be useful in delineating the steps in splicing assembly pathway that they affect. 
The analysis of defects in the assembly itself is now possible using improved methods of 
separation of splicing complexes on native gels, and the detection of binding of splicing 
components to pre-mRNA on solid supports. 
The assembly of snRNPs in wild type extracts using in vitro synthesised snRNAs 
are now being studied. Once the wild type pattern of assembly is known, study of the ef-
fect of inactivated mutant extracts or extracts from supressor strains on the assembly pattern 
of individual snRNPs and also their effects on multi-snRNP complexes (e.g. U4/U5/U6) 
can be attempted. Thus, a variety of tools necessary for a concerted biochemical and ge-
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netic analysis of pre-mRNA splicing are available, and analyses toward this end are in 
progress. 
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Fig la. The pathway of pre-mRNA splicing reactions. The reactions are described in the 
text. The intron-exon junctions are represented by vertical bars. The structure of the yeast 
branch is shown. 
Fig lb. Scheme for the assembly of the spliceosome. The snRNA content of each splicing 
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Fig 2. Representation of pre-mRNA and snRNA interactions. Base pairing of Ul and 
U2snRNPs with the 5' splice site and the branch sequence respectively has been demon-
strated genetically (see text). Binding of U5 snRNP is proposed to be mediated by a pro-
tein in mammalian systems. The U4 and U6 binding sites to the pre-mRNA are not 
known. Black circles represent Sm binding sites. [This fig. was contributed by P. Sili-



























































































































































Fig 3. Proposed pathway for the assembly of the spliceosome. The role of the RNA gene 
products in the assembly is indicated where known. 
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ABSTRACT 
Yeast introns contain three highly conserved sequences, which are known to be required 
for splicing of pre-mRNA. Using in vitro mutagenesis, we have synthesized seven point 
mutations at five different sites in these signals in the yeast actin intron. The mutant introns 
were then inserted into each of three constructs, which allowed us to assess the conse-
quences on splicing both in vivo and in vitro . In virtually every case, we found the effi-
ciency of splicing to be significantly depressed; mature mRNA levels in vivo ranged from 0 
to 47% of wild-type. Surprisingly, the tightest mutations were not necessarily at the sites of 
nucleolytic cleavage and branch formation; these nucleotides are thus highly preferred, but 
are not absolutely necessary. Moreover, while particular nucleotides are specifically re-
quired for the final step in splicing, i.e., 3' cleavage and exon ligation, the predominant 
consequence of mutation within the conserved signals appears to be the inhibition of as-
sembly of the splicing complex. 
INTRODUCTION 
The coding sequences of the majority of eukaryotic genes are interrupted by introns. The 
removal of intervening sequences by the process of RNA splicing is thus a fundamentally 
important step in gene expression, yet one which is only poorly understood at the molecu-
lar level. The most enigmatic aspect of this class of reactions is how the splice junctions are 
identified and juxtaposed, despite their separation in the primary structure by as many as 
100,000 nucleotides (Scott et al ., 1983; Garber et al ., 1983). 
Progress toward an understanding of this problem has been most rapid for the so-
called group I introns, which comprise the intervening sequences from nuclear and mito-
chondrial rRNA, many mitrochondrial mRNAs, and several chloroplast tRNA precursors 
(Michel eta/., 1982; Davies eta/., 1982; Michel and Dujon, 1983; Waring eta/ ., 1983; 
Cech eta/ ., 1983). These introns share a set of highly conserved structural elements that 
dictate a specific folding pattern. The folding opposes the intron/exon borders by align-
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ment against an "internal guide sequence." In fact, the three-dimensional geometry of this 
structure plays an even greater role, in that several of these precursors have been shown to 
undergo autocatalytic splicing in vitro in the complete absence of protein (Kruger eta/ ., 
1982; Garriga and Lambowitz, 1984; Vander Horst and Tabak, 1985). 
This situation contrasts sharply with the problem of splice site selection in metazoan 
nuclear mRNA precursors. Here the only conserved elements are restricted to short se-
quences at the 5' and 3' junctions (Mount, 1982). Even so, there is considerable variation 
about these averages, and more problematically yet, these sequences do not appear to be 
absolutely required for splicing, in that both cryptic and normal junctions are known that 
fail to obey even the 5' dinucleotide consensus (see, e.g., Mount and Steitz, 1983). A con-
siderably clearer picture has emerged from yeast, where analyses of intron sequences have 
revealed three highly conserved elements required for splicing. These are the 5' consensus 
sequence GTAPyGT, the 3' junction sequence PyAG, and the sequence TACTAAC that 
lies near the 3' junction and functions as the branch point (Dorndey et al ., 1984, Rodriguez 
eta/., 1984). Despite this stronger conservation at the level of primary sequence in yeast 
splicing signals, the challenge of explaining accurate juxtaposition of splice junctions with-
out the assistance of intron-mediated folding applies equally to lower and higher eukary-
otes. 
The missing pieces of the splice junction puzzle are likely to be found among the 
molecular components of the splicing machinery. Lerner and Steitz (1979) and Rogers and 
Wall (1980) first suggested that 5' and 3' junctions could be aligned via complementarity 
between these sequences and a stretch of 18 nucleotides at the 5' end of the U1 snRNA. 
While the U1 snRNP binds to the 5' splice site (Mount eta/., 1983), evidence does not 
support base pairing between the 5' end of U1 and the 3' splice site (Mount and Steitz, 
1981; Mount eta/., 1983). Rather, it appears that the 3' region of the intron provides 
binding sites for two snRNPs; the U2 snRNP binds and protects the branchpoint (Krainer 
and Maniatis, 1985; Black eta/ ., 1985), and US snRNP, probably,the 3' splice site 
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(Chabot et al ., 1985). From these results, a reasonable conjecture is that the splice sites 
are positioned via the interactions of the snRNPs with one another. Consistent with this 
notion is the observation that splicing intermediates in yeast (Brody and Abelson, 1985), as 
well as in HeLa (Grabowski et al ., 1985), are associated with a rapidly sedimenting, pre-
sumably multicomponent complex, named the spliceosome. 
A more detailed understanding of the relationship between splicing signals and the 
splicing machinery would benefit from the combined approaches of genetics and biochem-
istry. Toward this end, we have recently reported the use of gene fusions for the identifica-
tion and characterization of splicing mutations in Saccharomyces cerevisiae (Parker and 
Guthrie, 1985; Cellini et al ., 1986). Since the yeast splicing machinery, in contrast to that 
in mammals, does not use cryptic junctions (Gallwitz 1982; Pikielny et al., 1983; New-
man et al ., 1985), it has been possible to identify the molecular consequences of mutant 
signals. For example, we have previously shown (Parker and Guthrie, 1985) that mutation 
of the fifth nucleotide of the 5' consensus sequence results in pleiotropic effects that un-
couple three steps in splicing: 1) initial recognition of the 5' signal, 2) 5' cleavage and 
branch formation, and 3) 3' cleavage and ligation (as a consequence of aberrant cutting at 
an upstream site). 
Here we report an extension of this strategy for the systematic analysis of the ef-
fects of mutations within each of the three conserved signals in the yeast actin intron. Our 
results indicate that while certain residues are required specifically for the last step in splic-
ing, 3' cleavage and exon ligation, the predominant consequence of mutation within the 
conserved signals is the inhibition of assembly of the splicing complex. These findings are 
consistent with the view that the strength of interaction between cis -acting signals in the 




Using oligonucleotide directed mutagenesis (Newman eta/., 1983), we first generated a 
number of point mutations within the intron of the yeast actin gene (Ng and Abelson, 
1980). In order to monitor the consequences of these mutations both in vivo and in vitro, 
the mutant introns were then introduced into each of three constructs, as described in Fig-
ure 1. The first construct (pYAH-I2) is a fusion between the actin intron and the yeast 
HIS4 gene. The characteristics of this chimeric gene have been described previously 
(Parker and Guthrie, 1985). Briefly, accurate and efficient splicing of the actin intron al-
lows H/S4 deletion strains to grow on media containing the histidine precursor, histidinol 
(Hol; see Experimental Procedures). In addition, we can characterize the resultant tran-
scripts by using the biochemical methods described below. The ultimate appeal of this 
construction is in future studies, in which we can select suppressors of the original splicing 
defects by demanding growth on Hol. 
The second construct (pYAHB-2) utilizes a fusion to the E. coli beta-galactosidase 
gene. As we have shown (Larson eta/., 1983; Cellini eta/., 1986), this constructional-
lows a simple and rapid quantitative assay for the efficiency of splicing. Finally, to enable 
analysis of the intron mutants in vitro, an Alui fragment from the actin HIS4 fusion was 
transferred into an SP6 transcription vector. This allowed the convenient synthesis of mu-
tant precursors for subsequent analysis in the yeast splicing system recently described (Lin 
eta/.,1985). 
The yeast actin intron contains the sequence TACTAAG, just upstream of the 
TACTAAC box. We have previously reported that this sequence can function as a branch 
point in the absence of the authentic TACTAAC box (Cellini eta/., 1986). Moreover, the 
first mutation we analyzed in the TACTAAC box (A256, see below, Figure 4), activated 
this sequence as a branchpoint. To avoid the potential complication of this contribution in 
our further analyses, we deleted six nucleotides comprising this cryptic TACT AAC box 
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prior to the construction of additional mutants (see Figure 1 ). This deletion, referred to as 
~6, exhibits wild-type activity in all our splicing assays both in vivo and in vitro . 
In selecting our targets for site-directed mutagenesis, we were guided by the ratio-
nale that evolutionary conservation is indicative of a functionally important role. As we 
have discussed recently (see Guthrie et al ., 1986), the virtually 100% conservation at ev-
ery position within the splicing signals of Saccharomyces cerevisiae introns is rather non-
illuminating in this regard. In contrast, comparison of intron sequences from other fungi 
reveals more substantial variation within these signals (cf. Figure 6, Guthrie et al ., 1986) 
and thus allows the identification of particularly conserved nucleotides. Based on these ar-
guments, we constructed the mutations depicted in Figure 1. Mutations are designated as 
the nucleotide introduced and the position of the change within the actin intron, which is 
numbered from the 5' junction (/G is position 1) to the 3' junction (G/ is position 303. 
These include: 1) alteration of the first base of the intron from G to A or C (referred to as 
A1 and C1, respectively); 2) four mutations at three positions in the TACfAAC box, A256 
and T256, A257, and C259; and 3) alteration of the 3' splice site from CAG to CAC. 
(Because the dinucleotide immediately following the wild-type 3' junction is also AG, we 
constructed the double mutant, C303/305, changing the sequence at the 3' splice junction 
from CAG/AG to CAC/AC. In this construction, the next AG is 44 nucleotides down-
stream.) In addition, since the exon base next to the 5' junction is a G in approximately 
70% of all spliced genes (Mount 1982; Guthrie et al ., 1986), we altered this nucleotide to a 
C, designated CO. Finally, we have included the A5 mutation that we previously character-
ized in vivo (Parker and Guthrie, 1985). 
In vivo characterization 
Biological phenotypes 
As an inital assay for the level of splicing we determined the amount of 13-galactosidase ac-
tivity produced from the various mutations in the centromere plasmid p Y AHB2 depicted in 
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Figure 1. The plasmid was introduced into the yeast strain NNY 1 by transformation and 
Trp+ transformants were assayed for ~-galactosidase activity in liquid culture. With the 
exception of CO and T256, all mutations result in a significant reduction in enzymatic ac-
tivity and therefore presumably inhibit splicing (see Table 1). Transformants containing the 
A256 mutation exhibit the highest level of residual activity, about 47% activity relative to 
wild-type. Note that the level of ~ galactosidase expression for the A256 mutation in the 
L16 intron is significantly lower than that seen when the same mutation is present in a wild 
type intron; the significance of this will be discussed later. As indicated in Table 1, mutants 
in which residual splicing is between 30% and 50% exhibit a leaky Hoi+ phenotype. 
Transcript analysis 
The results of the ~-galactosidase assays suggested that most of the mutations produced 
major effects on splicing. As direct confirmation, we next analyzed the transcripts produced 
in vivo by the method of primer extension. For these experiments, yeast strain FC8-24D 
was transformed with the various mutant forms of pYAH-12 (see Figure 1). Poly(A)+ 
RNAs were prepared and used as templates in primer extension experiments, as detailed in 
Materials and Methods . 
Use of a primer located in the 3' exon allows us to examine the ratio of mature to 
precursor RNA and to determine the levels of lariat RNA molecules in the cell; note that this 
primer is derived from HIS4 sequences and is thus specific to the fusion in these cells (see 
schematic to Figure 2). As shown in Figure 2, in both wild type (lane 3) and delta 6 con-
structs (lane 4), only mature RNA (Band 2) is visible, indicating that the delta 6 deletion 
does not alter the efficiency of splicing in vivo. Consistent with the results from the lacZ 
fusion plasmids in Table 1, all mutations within the intron, with the exception of T256, re-
sult in strongly decreased levels of mature fusion mRNA. 
The A1 and C1 mutations, which correspond to alterations of the same nucleotide, 
produce unexpectedly different results. In the case of A1 (Figure 2, lane 7), the predomi-
43 
nant consequence is the accumulation of lariat molecules (Band 3), while there is a slight 
increase in the level of full-length precursor RNA (Band 1). This lariat RNA must be a 
dead-end product, since no mature mRNA is produced. In contrast, the Cl mutation (lane 
6) results in a barely detectable amount of lariat, while the major accumulated species is 
full-length precursor, as with A 1, no mature RNA can be detected. As observed previously 
(Parker and Guthrie, 1985), the A5 mutation causes the accumulation of full-length precur-
sor as well as some lariat species; mature mRNA production is decreased relative to wild-
type. 
Three mutations in the TACTAAC box, A256 (cf. lane 4, Figure 3; lane 6, Figure 
4), A257 (lane 10, Figure 2), and C259 (lane 11, Figure 2) cause a dramatic accumulation 
of precursor molecules. The finding that C259 does, however, produce some mRNA is 
interesting, since it is the branch point nucleotide that is altered. In fact, the A257 mutation, 
which is two nucleotides 5' to the site of branch formation, produces a stronger inhibition 
of production of mature message. These differences are also reflected in the ~-galactosidase 
levels (cf. Table 1). 
The C303/C305 mutation is unique in that it appears to affect only the last step of 
the splicing pathway. As seen in Figure 2, lane 12, there is no detectable full-length 
precursor, suggesting that 5' cleavage and lariat formation takes place efficiently, while 
there is a dramatic accumulation of molecules with the mobility of lariats, consistent with a 
block in 3' cleavage and ligation. It is interesting to note, however, that a low but detectable 
level of mRNA-sized molecules is found, despite the presence of a Cat the 3' cleavage site. 
(Evidence that cleavage is occurring at this residue, i.e., AC/, is presented below). 
The interpretation of each of the preceding results was confirmed by additional 
primer extension experiments. As shown in Figure 3, the use of an oligonucleotide primer 
situated 46 nucleotides downstream of the 5' splice junction reveals the accumulation of 
molecules indicative of full-length precursor for mutants C1 (lane 1), A1 (lane 2), A5 (lane 
3) A256 (lane 4), C259 (lane 5) and A257 (lane 8). We also observe the accumulation of 
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presumptive lariat species in the case of A1, C303/305, and to a much lesser extent, A256 
(lane 4). In the latter cases we can thus also conclude that the position of the 5' cleavage is 
unaltered as the result of mutation at the indicated positions. As we have reported previ-
ously (Parker and Guthrie, 1985), this is not the case when the fifth position of the 5' 
junction is altered; the AS mutation activates an aberrant cleavage site upstream of the nor-
mal splice site (see Figure 3, lane 3). 
To confirm that the primer extension block at the TACT AAC box assigned to the 
lariat species is indeed due to a branched species, we made use of an enzymatic activity that 
hydrolyzes 2'-5' phosphodiester bonds (Ruskin and Green, 1985). Treatment of branched 
molecules with this "debranchase" has been shown to remove the block to reverse tran-
scription and allow the enzyme to extend to the 5' terminus of the RNA template, in this 
case the 5' intron/exon junction. In the experiment shown in Figure 4, we used a primer 
that is located near the branch site in order to facilitate precise mapping of the branchpoint. 
As can be seen most clearly for C303/305, the band corresponding to the lariat block (band 
3, lane 12) is almost completely abolished following prior incubation with debranchase 
(lane 11). Note the concomitant appearance of a novel species with the appropriate mobility 
for molecules cleaved at the 5' junction (lane 11, band 2). 
Comparable results are seen for A1 (Figure 4, lanes 15, 16) and C259 (Figure 4, 
lanes 7, 8). The latter finding is particularly important, as we noted above, because the 
C259 mutation alters the branch point nucleotide. The fact that the branch still forms at the 
correct position demonstrates that the chemistry of branch formation is not limited to a 2'-5 
phosphodiester linkage between G1 and an A residue. Apparantly a 5'G-2'C linkage can 
also form, albeit inefficiently. This result is in interesting contrast to the situation in A256 
when this mutation is present in an otherwise wild-type (i.e., non- L16) intron background. 
A debranchase-sensitive stop is apparent not only at the normal position (Figure 4, Band 3, 
lane 5 cf. lane 6), but also at the upstream cryptic sequence (Figure 4, Band 4); the latter 
primer extension stop maps precisely to the last A of the cryptic TACT AAG box. Thus de-
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spite the presence of the normal branch point nucleotide, the A256 mutation activates the 
use of the cryptic site (see Cellini et al ., 1986). That this is a productive branchpoint is in-
dicated by the observation that ~-galactosidase levels are reproducibly higher in strains car-
rying the cryptic element as compared to those in a ~6 background (cf. Table 1). 
In vitro analysis 
The results of the preceding analyses demonstrate that, with the exception of T256, each of 
the intron mutations we constructed had drastic consequences on the efficiency of the 
splicing reaction in vivo . Moreover, with the exception of C303/305, the defect was pri-
marily manifested by the accumulation of full-length precursor molecules. We next sought 
to confirm these results in vitro . Two additional pieces of information were also of inter-
est. First, in that the in vivo data are perforce restricted to steady state analyses, we wanted 
to determine whether additional effects could be discerned by kinetic analyses. Second, we 
were particularly curious to learn if the accumulation of precursor molecules could be more 
specifically attributed to one of two possible blocks, 5' cleavage per se, or the earlier event 
of spliceosome assembly. 
In vitro splicing assay 
We first assayed the ability of the the mutant substrates to be spliced in vitro. In these ex-
periments, radioactive precursor generated by in vitro transcription with SP6 polymerase 
was incubated for various times in an active splicing extract, and the products of the reac-
tion were separated by polyacrylamide gel electrophoresis. Figure 5 shows the now famil-
iar products of splicing that are obtained with wild-type or ~6 actin precursor. The ligated 
mRNA product (Figure 5a, band 5) can be seen to accumulate with time. The excised in-
tron is released as a lariat (Figure 5a, band 4), which characteristically (Ruskin eta! ., 
1984; Domdey et al ., 1984) migrates more slowly than the precursor (Band 1). Two in-
termediates are seen, the free 5' exon (Figure 5a,band 3), and the most slowly migrating 
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form, the intron-exon 2 lariat (Figure Sa, band 2). The same results are seen for the CO 
mutation (Figure 5d), confirming that this change has no detectable effect on recognition of 
the 5' splice site and its utilization for splicing. 
The three 5' splice site mutants, Al and Cl (Figure 5b and c) and A5 (data not 
shown), are completely inactive in vitro; only full-length precursor is detected, indicating 
that the block has occurred at a step prior to the flrst nucleolytic event of splicing. The same 
result is found for the mutations in the TACT AAC sequence, A256 and A257 (Figure 5e 
and 5f) and C259 (data not shown). In that the C259 mutation is detectably leaky in vivo 
(7% by 13-galactosidase assay), we attempted to force the in vitro analysis by using sub-
stantially nuclease free extracts thereby permitting prolonged incubations with precursor 
RNA. As shown in the last panel of Figure 5, under these conditions, which entail use of a 
35% ammonium sulfate precipitation of the whole cell extract, small amounts of intron lar-
iat can be observed during long periods of incubation. We attribute the failure to detect the 
production of NS-exon2 to insufficient sensitivity, in that this species is typically found at 
about 25% the level of the excised intron if utilization of the lariat intermediate in the second 
nucleolytic step is efficient 
In the 3' splice site mutant C303/C305, the in vitro results again mimic our fmdings 
in vivo . As shown in Figure 6(a), lariat intermediate and exon 1 accumulate (Band 2), but 
no mRNA product is formed; thus the second nucleolytic step in splicing is completely in-
hibited. This 3' splice site mutant was of particular interest in light of the conclusion from 
our in vivo analyses (cf. Table 1 and Figure 2) that some low level cleavage was occurring 
at the correct position with respect to the 3' junction, despite the change in nucleotide se-
quence. To provide more direct evidence for this hypothesis, we turned to the 35% ammo-
nium sulfate pellet of the whole cell extract, which generated a small but detectable amount 
of excised lariat intron (Figure 6b). This product has the same electrophoretic mobility as 
the wild-type lariat intron and hence cannot result from cleavage at a sequence downstream 
of the now mutant 3' splice site. To determine the exact site of cleavage, RNase Tl finger-
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print analysis of the excised intron was performed. Figure 7a shows the pattern for the ~6 
intron, which contains the oligonucleotide UUUAG-OH derived from the 3' junction 
(designated as 14' by Lin eta/., (1985)). This spot is missing in the T1 fingerprint from 
the mutant C303/305; as shown in Figure 7b, it is replaced by a spot whose mobility is 
consistent with a single base change, as expected for the mutation of the terminal G to a C. 
Consistent with this observation, T1 oligonucleotide from the intron-exon2 junction 
ACACG was not seen in the T1 fingerprint of the mutant intron (Figure 7b). To prove the 
identity of this product, a transcript was prepared by labelling with a._32p CTP and the ex-
cised intron was isolated. The putative 3' terminal Tl oligonucleotide UUUAC-OH was 
incubated with pancreatic ribonuclease A; separation of these products by thin layer chro-
matography revealed the presence of the predicted labeled product Ap*C-OH (data not 
shown). We conclude that the mutation of the splice junction from PyAG/ to PyAC/ de-
creases the efficiency but not the fidelity of the 3' cleavage reaction. 
Spliceosome assembly 
As first reported by Brody and Abelson (1985), Figure 8a shows that exogenous labeled 
precursor (in this case the ~6 transcript) when incubated with splicing extract, is incorpo-
rated into a complex that sediments at 40S in a glycerol gradient. The peak fractions contain 
full-length precursor, the reaction intermediates and excised intron, but they are deficient in 
mRNA (Brody and Abelson 1985). Formation of this complex is A TP-dependent; in the 
absence of ATP, a 30S complex forms (Fig 8a; Brody and Abelson, 1985), which contains 
unspliced precursor only. 
Figure 8b, c, and e-g shows the strikingly uniform finding that the three 5' splice 
site mutants A1, Cl and A5, and each of the mutations in the TACTAAC sequence, A256 
(data not shown), A257 and C259, block formation of the 40S complex; 30S complex is 
apparently unaffected. These results are in dramatic contrast to the behavior of the 3' splice 
site mutant C303/305 transcript. As shown in Figure 8h, this precursor assembles as effi-
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ciently as does the .16 control into a species whose mobility (40S) is indistinguishable from 
that of the parental complex. This observation is consistent with the demonstration that the 
C303/305 mutant is capable of undergoing the first nucleolytic event in splicing in vivo and 
in vitro, 5' cleavage and branch formation. As shown in Figure 8d, the CO mutation, which 
permits efficient splicing in vivo, also enables the formation of the spliceosome in vitro. 
DISCUSSION 
Genetic dissection of splicing in vivo 
At our current level of understanding, three stages of nuclear pre-mRNA splicing can be 
operationally identified. As cartooned in Figure 9 for yeast, the process appears to be initi-
ated by an A TP-dependent assembly reaction, which results in the formation of a rapidly 
sedimenting complex, the spliceosome (Brody and Abelson, 1985; Grabowski eta/., 
1985; Fredneway and Keller, 1985). Cleavage at the splice junctions and subsequent liga-
tion then proceeds by a two-stage reaction. In the first step, the 5' end of the intron forms 
an intramolecular branch via a 2'-5' phosphodiester bond with the 3'-most A in the TAC-
TAAC box, creating a lariat structure. In the second step, the 3' exon is joined to the 5' 
exon, accompanied by the release of the intron lariat. In contrast to the Group I and Group 
II introns in protozoan rRNA and certain organellar tRNA and mRNA precursors (Michel 
eta/., 1982; Michel and Dujon, 1983), the only cis elements that are likely to mediate these 
events are confined to short sequences at the sites of nucleolytic cleavage and branch for-
mation. 
By mutational alteration of each of these three conserved signals in the yeast actin 
intron, we have sought in a systematic fashion to determine the specific contribution of in-
dividual nucleotides to the mechanism of splicing. In the first level of analysis the goal is to 
dissect the pathway into its component partial reactions and to assess the relationship of 
these steps to one another. Moreover, the response of the system to mutational perturbation 
of the substrate should be indicative of fundamentally important aspects of the splicing rna-
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chinery. The ultimate potential of a genetic approach would be realized by the use of these 
mutant signals for the direct identification of mutations in the components that interact with 
them. 
Evolutionary conservation identifies critically important nucleotides in multiple steps in the 
splicing pathway 
Our choice of nucleotide alterations was based on the observation that certain positions 
within these signals show higher conservation than others, if introns from a variety of fila-
mentous fungi are included in addition to Saccharomyces cerevisiae in the sequence com-
parisons (cf. Guthrie et al ., 1986). In keeping with the prediction that evolutionary con-
servation would identify functionally critical residues, we have found that alteration of each 
of the five positions tested has severe consequences on splicing efficiency. With one ex-
ception (see below), residual mature mRNA levels ranged from undetectable to 47% of 
wild type, measured by ~-galactosidase production. Consistent with this prediction, both 
Jacquier eta/ . (1985) and Fouser and Friesen (1986) have recently shown that mutations 
in less conserved positions have comparably less dramatic effects on the level of mRNA 
production. 
While alteration of each of the three signals had profound effects on splicing, the 
consequences of individual mutations were quantitatively and qualitatively distinct. For ex-
ample, the conservative transition mutation at the third position of the TACTAAC box 
(T256) has an undetectable effect on the level of mRNA formation, while the C to A 
transversion at the identical position (A256) reduced mRNA production by 50%. A singu-
larly dramatic example of qualitative differences is provided by considering the effects of 
mutation of the first base of the intron from G to C (Cl) or to A (A1). In the case of C1, 
only full-length precursor is observed and while precursor levels in A1 are also elevated 
relative to the parental control, the predominant block is in the conversion of lariat interme-
diates (Figure 9, Step 4). This suggests that a particular position may participate in more 
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than one reaction in the splicing pathway, while the specific requirements for the chemistry 
of these individual reactions may differ considerably. Thus a pyrimidine may not be toler-
ated in one or more steps leading to 5' cleavage and branch formation (Figure 9, steps 1-3), 
while an A residue is acceptable until step 4. The apparently absolute requirement in 3' 
cleavage for a G residue at the 5' position of the branch has been discussed previously ( 
Newman eta/., 1985; Parker and Guthrie, 1985). 
Site specificity of bond breakage/formation is not dependent on the conserved nucleotides 
at these postions 
The surprising finding that 5' cleavage could occur, albeit inefficiently, in the absence of 
the completely conserved G at the intron border (Newman eta/ ., 1985; Parker and 
Guthrie, 1985) can now be extended to 3' cleavage. That is, replacement of the invariant G 
at the 3' junction by a C residue (C303/305) does allow a low level of splicing via cleavage 
at this mutant site. Since no downstream sequences are utilized as 3' splice sites, the site 
specificity for the low level of cleavage at the mutant site could be conferred by the distance 
from the TACT AAC sequence or the sequence context around this mutant site. Moreover, 
we have shown that replacement by a C (C259) of the absolutely conserved A residue, 
which provides the 2' hydroxyl in the generation of the lariat, permits unexpectedly effi-
cient branch formation at the mutant residue. This forces us to conclude that, their extraor-
dinary evolutionary conservation notwithstanding, the specific residues at the sites of nu-
cleolytic cleavage and branch formation are highly preferred, but not absolutely required. 
Indeed, the contribution of these nucleotides is most apparent in modulating the efficiency 
of the reactions in which they participate. The significance of this observation is under-
scored by our previous demonstration that, at least for the case of 5' cleavage, the speci-
ficity of the reaction, while unaffected by the mutation at the site of bond breakage (A1, 
C1), can nonetheless be altered in response to mutation elsewhere in the signal (A5) 
(Parker and Guthrie, 1985). 
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The mechanistic basis for the loss of specificity observed in the A5 mutant remains 
to be elucidated. Nonetheless, we have concluded previously that the aberrant cleavage up-
stream of the intact junction (!GT) is dependent on prior recognition of the 5' consensus 
sequence, presumably by the yeast equivalent of the Ul snRNP. This argues for the critical 
role of trans-acting factors in determining the sites of subsequent catalytic events. We can 
now extend this principle to the case of branch site selection. We have shown that when 
present in an otherwise wild-type actin intron background, the A256 mutation activates 
branch formation at the upstream, sequence T ACf AAG box. This cryptic site, while it is 
normally not used, has been demonstrated by us (Cellini eta/., 1986) to be activated when 
the wild-type TACTAAC is deleted. This suggests that the A256 mutation disrupts an im-
portant recognition contact, and thus allows an otherwise inactive T ACf AAC box to com-
pete for binding by a factor which, in analogy to results from HeLa (Chabot et al ., 1985; 
Krainer and Maniatis, 1985), is likely to be the yeast analogue of the U2 snRNP. As a test 
of this hypothesis, it would be of interest to determine whether A257 (which is currently 
available only in the ~6 background) would also lead to activation of teh cryptic T AC-
TAAC box. Since this mutant is phenotypically much tighter than A256, we would predict 
that (i) its binding site is comparably weaker and (ii) it should thus promote more effective 
competition by the cryptic element. 
The picture that emerges from these considerations is one in which the primary de-
terminants of the efficiency and specificity of the splicing reactions per se (Figure 9, Steps 
3 and 4) are the strength of the interactions between the splicing signals and trans-acting 
recognition factors (Steps 1 and 2). Indeed, the most important interactions do not neces-
sarily involve the nucleotides at the sites of bond breakage/formation. According to this 
view, the predominant consequence of mutations which inhibit splicing should be mani-
fested by the decreased binding of these factors, that should minimally include the snRNPs 
themselves (Black eta/., 1985; Chabot et al ., 1985; Krainer and Maniatis, 1985). We 
have previously demonstrated that Saccharomyces cerevisiae contains snRNAs (Wise eta! 
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., 1983) and, more recently, that a subset of these capped species are 1) essential for splic-
ing in vitro (Cheng and Abelson, 1986) and 2) enriched in the spliceosome fraction (Riedel 
et al ., in preparation). An initial test of this hypothesis is to assay the ability of these mu-
tants to assemble a splicing complex in vitro. 
Spliceosome assembly is rate-limiting in vitro 
While only two of the six intron mutants analyzed do not undergo detectable splicing in 
vivo (AI, C1), only a single mutant (C303/305) showed any activity in the standard in 
vitro splicing assay. While the specific explanation for this discrepancy is not known at this 
time, it is likely that the in vitro system is still sub-optimal with respect to one or more re-
actions in the pathway. As such, it would provide a more stringent test for the ability of a 
mutant substrate to undergo the respective event. Consistent with this reasoning is the 
demonstration that C259 undergoes a low-level of splicing in vitro only if the extract is first 
concentrated by ammonium sulfate precipitation, suggesting that the effective concentration 
of one or more components may be limiting. 
To determine whether the failure of these mutants to undergo splicing was due to a 
block at or prior to the first nucleolytic event in the pathway, 5' cleavage and branch for-
mation (Step 3), the extracts containing each of these precursors were assayed for their 
ability to form the 40S complex first described by Brody and Abelson (1985). With the ex-
ception of C303/305 (see below), no appreciable spliceosome assembly could be detected; 
rather the mutant precursors sedimented at the 30S position characteristic of wild-type sub-
strates incubated in the absence of ATP. We conclude that each of these mutants is unable 
to participate efficiently in Steps 1 and/or 2, i.e., signal recognition and complex assembly. 
It is important to note that this conclusion by no means excludes the possibility that addi-
tional steps are also affected in vivo . For example, there is ample evidence that the A 1 
mutant, in addition to accumulating full-length precursor, is also defective in conversion of 
lariats (Step 4) in the cell. As we have discussed above, the most reasonable interpretation 
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is that the AI mutation has pleiotropic effects; the most proximal in the pathway-- and per-
haps the one most evident by a kinetic analysis --is the block in complex formation. 
In this light it is of considerable interest to contrast the in vitro behavior of A 1 with 
that of C303/305, which appears to be selectively inhibited in Step 4 both in vivo and in the 
in vitro splicing assay. Not only is this the sole case in which we can detect 40S complex 
formation in vitro, but the efficiency of the C303/305 assembly reaction is indistinguishable 
from that of wild-type. This suggests that the essential interactions between splicing signals 
and trans-acting factors that govern spliceosome assembly do not require recognition of the 
3' terminal G of the 3' junction. These results are consistent with the observations of Ry-
mond and Rosbash (1985) and Reed and Maniatis (1985). 
We conclude that requirements for 3' cleavage and exon ligation (Step 4) appear to 
be highly restricted: the presence of a G at the 5' position of the branch point is essential, 
while a G at the 3' splice site itself is highly preferred but not absolutely demanded. More-
over, since the 5' branch position also plays a critical role in other reactions, C303/C305 is 
the only mutation analyzed that specifically affects Step 4 of the pathway. 
Implications 
The observation that most mutation examined had a marked effect on precursor accumula-
tion in vivo and completely inhibited spliceosome assembly in vitro argues, as we have 
discussed above, that the splicing reaction in yeast is dominated by the strength of the in-
teractions between the splicing signals at the 5' splice junction and the branchpoint and one 
or more trans-acting factors. These interactions are likely to mediate two steps in the splic-
ing pathway, initial recognition (Step 1) and spliceosome assembly (Step 2). 
Further experiments are required to distinguish experimentally between these two 
steps. In the meantime, we would speculate that each of these reactions can contribute to 
the effects we have observed. The primary sequence and local structure of a splicing signal 
almost certainly influences Step 1; the behavior of the A256 mutation, for example, is most 
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plausibly accounted for by a competition governed by these features. Cl and A257 may 
represent more extreme cases, in which no sufficiently stable trans interactions can be 
maintained. In addition, we think it likely that the efficiency with which a given intron is 
spliced will be determined by snRNP-snRNP interactions that may promote, or inhibit, the 
formation (and/or stability) of the complex (Step 2). In this regard it is perhaps relevant to 
compare the quantitative effects of identical mutations that have been observed in different 
yeast introns. The A 1 mutation in the CYH2 intron (Newman et al ., 1985) has a much less 
drastic effect on complex formation and 5' cleavage than the same mutation in actin; con-
versely, the C259 mutation has a tighter phenotype in CYH2 than in actin. Conceivably, 
then, the relative strengths of 5' and branchpoint signals are coordinated, via interactions in 
trans, to set the effective efficiency of any given intron. 
The emergent picture is thus one in which a specific three-dimensional architecture 
is imparted to the intron by a stepwise association of 1) snRNAs with their cis signals, and 
2) snRNAs and snRNPs with one another, via a combination of RNA/protein interactions. 
Together with the fact that the nucleolytic events of splicing occur by two sets of reactions 
in which the total number of bonds is conserved, these considerations suggest the 
provocative possibility that the mechanism of splicing of nuclear pre-mRNA introns may 
be fundamentally similar to that in Class I and Class II introns. As recently suggested by 
Cech (1986), splicing in both systems would occur by successive trans esterification reac-
tions. In the latter case, the autocatalytic capacity is inherent in the intramolecular interac-
tions within the intron; in the former, this structure is imparted to the intron by the inter-
molecular interactions between the signals and the snRNPs. The recent demonstration that 
Class II introns self-splice via a lariat intermediate makes this suggestion quite credible 
(Peebles et al ., 1986). 
A prediction of this model is that the components of the splicing machinery will not 
include "conventional" enzymes such as the ligase and endonuclease that mediate tRNA 
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splicing (Peebles eta!., 1983; Greer et al., 1983). The genetic and biochemical dissection 
of this machinery is currently underway. 
MATERIALS AND METHODS 
Materials 
Restriction enzymes were purchased from New England Biolabs. 32P-ATP was pur-
chased from ICN; a-P32UTP and a-p32 CTP were purchased from Amersham. Reverse 
Transcriptase was obtained from Life Science. Oligonucleotides (Table 2) were synthesized 
using an Applied Biosystems machine. RNasin and SP6 RNA polymerase were obtained 
from Promega Biotech. Yeast media was prepared as described by Sherman et al. (1979). 
Oligomutagenesis 
The template for oligomutagenesis, MP9.sal was construted by insertion of the 1.4 kb Sali 
fragment from pYAH-12 (Parker and Guthrie, 1985) into the San site of MP9. Oligomuta-
genesis was preformed by a procedure described in Newman et al ., (1983) with some 
modifications. Oligonucleotide primed extension was followed by transformation of E. coli 
JM101 ( L\lac pro supE thi, F:traD36, proAB, laclq Z L\M15) with an aliquot of the ex-
tension products without the separation of the closed circular product from the reaction 
mixture. Screening for the mutant plaques was done as described by Newman et al ., 
(1985). The sequence of each mutation was confirmed by sequencing using oligonucleotide 
primers that hybridized to regions of the actin gene downstream of the position being 
mutagenized, by the method of Sanger et al ., (1977). 
Plasmid and strain construction 
Mutations were subcloned into the test vectors by the following procedures. For pYAH-12, 
a plasmid was constructed deleting the 1.4 kb Sal I fragment. This plasmid, pYAH-I2 ( 
L\Sal I), was cleaved with Sal I and the 1.4 kb Sal I fragment from the MP9 RF and was 
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inserted in the correct orientation. This plasmid was introduced into the yeast strain FC8-
24D (Parker and Guthrie, 1985) and targeted to the HIS4 locus by cleavage with Xba I. 
Integrations were confirmed by Southern (1975) analysis. For p Y AHB2, the Bam lll - Sal 
I fragment containing the intron was subcloned into the Bam ill-Sal I sites adjoining a de-
fective lacZ gene, CENIII, TRP-ARS 1 containing vector pcGL (unpublished) and intro-
duced into the yeast strain NNY1 (Cellini eta/., 1986) by transformation. Transformations 
were done by the method of Ito et a/ ., (1983). For the SP6 constructions, an the Alui 
fragment containing the intron and portions of exon 1 and exon 2 were subcloned into the 
Smai site of the Sp6 transcription vector SP65. 
Preparation of RNA and primer extension analysis 
RNA was prepared as described by Domdey et al ., (1984). Primer extensions were per-
formed as described by Domdey et al ., (1984). 5 micrograms of poly(A)+RNA was used. 
In vitro transcription 
Actin transcripts for the in vitro splicing reactions were synthesized in a 10 J.ll reaction 
containing 20 mM NaCl, 40 mM Tris-HCl, pH 7.5, 6 mM MgCl2 2 mM spermidine, 10 
' 
mM DTT, and 0.5 mM of each of the unlabelled nucleotides CTP, ATP, GTP and 25 mM 
UTP and a-P32 UTP at 1 mCi/ml, 1000 U/ml RNasin (Promega Biotech), 50-100 ug/ml 
linearized template (linearized with Hindiii) 400 U/ml Sp6 RNA polymerase (Promega 
Biotech). To prepare a- p32 CTP labeled actin transcripts 20 J.ll reactions were done con-
taining 5 mCi/ml a-P32 CTP with the concentration of the other unlabelled nucleotides be-
ing at 0 .5 mM. These reactions were done at 370C for two hours. The full-length tran-
scripts were purified by gel electrophoresis. 
In vitro splicing reactions 
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Standard splicing reactions were carried out as described in Newman et al ., (1985). Ex-
tract used in this study were either whole cell extracts of the yeast strain EJ101 (Lin et al ., 
1985) or more concentrated ammonium sulfate fractions of the whole cell extract that had 
complete splicing activity. Two different fractions were used. One a 35% ammonium sul-
phate pellet (McFarland and Abelson, unpublished results) for which 2.0 M potassium 
phosphate was added to a final concentration of 0.25 M to the whole cell extract. Ammo-
nium sulphate was then added to 35% saturation and stirred on ice for 30 minutes. The 
pellet was recovered by centrifugation at 17,000 rpm for 30 min (Sorvall SS34) and then 
resuspended in one-tenth the volume of the crude extract used in the fractionation. Dialysis 
was done against Buffer D (Newman et al ., 1985) for four hours with one change of 
buffer after two hours. The extract was spun in an Eppendorf Microfuge for one minute to 
remove insoluble material and the supernatant frozen at -700C. The extracts had complete 
splicing activity. The other fraction used was a 40% ammonium sulphate cut of the whole 
cell extract without adjustment of phosphate (Cheng and Abelson, 1986). 
RNA structure analysis 
The RNase digestions were done according to Domdey eta/., (1984). For fingerprinting 
and secondary analysis, the T1 digest was separated in the first dimension cellulose acetate 
membrane electrophoresis, pH 3.5, and in the second dimension by homochromatography 
on polyethleneimine (PEl) cellulose TLC plates. For secondary analysis (Domdey eta/., 
1984) of the oligonucleotide, elution was done with 30% triethylamine bicarbonate, pH 10, 
followed by appropriate RNA digestions. Two-dimensional TLC on PEl plates was done 
for the Tl and A ribonuclease double digest. 
Gradient analysis of in vitro splicing reactions 
In vitro splicing reactions with 2-3 x 104 cpm (counted as Cerenkov) of precursor were 
used in a 100 ul splicing reaction containing 40 ul of the 40% ammonium sulphate pellet of 
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the yeast whole cell extract. Reactions were carried out for 15 min at 230C and then lay-
ered on a 17% to 32% glycerol gradient, containing 20 mM HEPES pH 7 .3, 100 mM KCl, 
2 mM MgCl2, 0.2 mM DTI. Centrifugation of the gradients was done at 39K rpm for five 
and half hours in an SW41 rotor at 2oc. Fractions were monitored by Cerenkov counting. 
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TABLE 1: BIOLOGICAL EFFECTS OF INTRON MUTATIONS 
Mutation Relative I)-galactosidase Growth on 
activity histidinol 
Wild-type 100% + 
.16 110% + 
CO( .16) 97% + 
C1( .16) 0.5% 
A1( .16) 0.4% 
A5 45% +I-
T256 98% + 
A256 47% +I-
A256( .16) 8% nt 
A257( .16) 2% 
C259( .16) 7% 
C303/ C305( .16) 2.4% 
Relative values for I)-galactosidase activity were derived from four to seven independent 
measurements for each of the constructs. Assays were performed as described previously 
(Larson et al ., 1983). Mutations in the wild-type intron were compared to the wild-type 
construct; mutations in the .16 intron were compared to the .16 control. 
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Fig 1. Intron Mutations and Plasmid Constructions 
The starting plasmid, pM9. Ll6 is shown along with an expanded version of the actin in-
tron. Using this plasmid, oligonucleotide site-directed mutagenesis was performed to con-
struct the mutations shown. Mutations are designated by the nucleotide change and the nu-
merical position within the intron (i.e., A 1 represents the introduction of an A residue at the 
flrst position of the intron). All mutations are present in the 6 background (see Materials 
and Methods) except for AS, T256 and A256, which are present in an otherwise wild-type 
intron. Symbols for fusion sequences: open rectangle, actin exons; thin line, actin intron; 
hatched areas, HIS4 gene; dotted areas, E.coli lacZ gene. The SP6 promoter is shown 
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Fig 2. Primer Extension from the 3' Exon 
Poly(A +)RNA was prepared from FC8-24D transformed with either the wild-type or mu-
tant derivatives ofpY AH-12 (see Figure 1) and was treated to primer extension as described 
in Materials and Methods. The primer for this experiment is the 21mer, 5' CTCTTCAT-
TACTCAGGCTCGA 3', which hybridizes specifically to the actin-H/S4 junction. In the 
schematic beside the gel, actin sequences are shown as open boxes, intron sequences as a 
solid line, and HIS4 sequences as slashed boxes. Samples in each lane are as indicated by 
the heading above the gel. Abbreviations are; UT, untransformed FC8-24D, WT, wild-type 

































































































































































































































































Fig 3. Primer Extension from a Primer 5' of the Branch Point 
Poly(A)+ RNA was prepared from FC8-24D and subjected to primer extension analysis as 
described in the Materials and Methods. The primer for this experiment is the oligonu-
cleotide, 5' AATTCITCTTACAGTTAAATGG 3', which hybridizes to the intron 46 nu-
cleotides 3' of the 5' splice site (see schematic). Samples in each lane are denoted above the 
gel. Because the host strain for these experiments is deleted for the chromosomal actin in-
tron (Parker and Guthrie, 1985) all eDNA products are derived from the fusion transcripts. 
The sequencing ladder used for positioning primer extension stops was generated by se-
quencing off M13. 8.6 with the same kinased primer. Lanes are labeled as the nucleotides 
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Fig 4. Position of Branchpoints in Splicing Mutations 
Poly(A)+ RNA was prepared from the strain FC8-24D transformed with either the wild-
type or mutant derivatives of pYAH-12 (see Figure 1), and was used for primer extension 
with or without prior debranching as described in Experimental Procedures. The primer for 
this experiment is the 24mer, 5' CTAAACATATAATATAGACACAAA 3', which hy-
bridizes to the 3' end of the intron. The sequencing ladder used for positioning primer ex-
tension stops was generated by sequencing off M13. 6 with the same kinased primer. 
Lanes are labeled as the nucleotides found in the RNA strand. Size markers are 5' end-la-
beled Hpaii cut pBR325. The eDNA products of approximately 70 nucleotides found in 
RNA preparation containing full-length precursor correspond to a nine nucleotide helix that 
appears to generate both reverse transcriptase stalling and specific degradation products in 
the debranchase reaction. 
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Fig 5. In vitro Splicing of Mutant Substrates 
The figure illustrates the products of in vitro splicing (see Materials and Methods) for either 
wild-type or mutant substrates. The mutation in the input precursor is indicated above each 
set of lanes, wt represents wild-type. Bands are as follows: band 1, input full-length pre-
cursor; band 2, lariat intermediate; band 3, free exon 1; band 4, excised lariat intron; band 
5, mature ligated mRNA. The mature mRNA for the wild-type construct is slightly shorter 
than the ~6 construct due to a smaller exon 1. This is a result of being in a different SP6 
transcription vector. Similarly, the input precursor for A256 is slightly shorter because it is 
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Fig 6. In vitro Splicing of the C303/C305 Mutation 
This figure illustrates the products of in vitro splicing for the C303/C305 mutation. Panel A 
is using a normal whole-cell extract. Panel B is using a 35% ammonium sulfate pellet 
(described in Materials and Methods), which allows the detection of some excised intron 
(band 4). Bands are labeled as follows: band 1, input precursor; band 2, lariat intermediate; 
band 3, free exonl; band 4, excised intron. 
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Fig 7 . Fingerprint Analysis of the Excised Intron for C303/C305 
The excised intron for ~6 and C303/C305 mutant (band 4 in Figure 6) was purified and 
subjected to fingerprint analysis as described in the Materials and Methods. The Tl 
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Fig 8. Complex Assembly Assays for Mutant Substrates 
The figure shows the glycerol gradient profile of hot precursor following incubation in a 
splicing extract (see Materials and Methods). In panel A the solid line represents the profile 
in the abscence of A TP, the dotted line represents the profile in the presence of A TP. In all 
other panels the solid line represents the mutant precursor, the dotted line represents a 

















































































































































































































































































































































































































































Fig 9. Putative Splicing Pathway 
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ABSTRACT 
In this study we report the isolation of temperature sensitive mutants that affect pre-mRNA 
splicing. A bank of about one thousand temperature sensitive (ts) S. cerevisiae strains was 
generated and screened on RNA gel blots. We have isolated eleven new complementation 
groups fprp (rna )17-27 ], representing four phenotypic classes of mutants. The majority 
of the complementation groups share a phenotype of pre-mRNA accumulation, a phenotype 
also seen in all of the prp (rna )2-11 mutants. Three novel classes of mutants were isolated 
in this study. One class, consisting of two complementation groups, exhibits an 
accumulation of the lariat intermediate of splicing, with no change in the levels of pre-
mRNA. The second class, also represented by two complementation groups, shows an 
accumulation of the intron released after splicing. The third novel class, comprising one 
group, accumulates both pre-mRNA and the released intron. All mutants isolated were re-
cessive for the splicing phenotype. Except for two complementation groups all other 
groups contain alleles where co-segregation of the ts defect and the splicing phenotype is 
observed. This study together with previous isolation of the prp (rna )2-11 groups puts at 
least twenty-one gene products involved directly or indirectly in pre-mRNA splicing. 
INTRODUCTION 
The precise removal of the intron from nuclear pre-mRNA is an essential process in eu-
karyotic gene expression. The splice site selection in nuclear pre-mRNA is dictated only by 
short stretches of sequences at or near the splice junctions (Shapiro and Senapathy 1987). 
The elucidation of a two-step splicing reaction scheme has come through the development 
of in vitro splicing systems; where the first step is cleavage at the 5' splice site and the for-
mation of a lariat structure, and the second step is cleavage at the 3' splice site and ligation 
of the exons (for reviews see Green 1986; Padgett et al., 1986 and Sharp 1987). The 
splicing reaction takes place in a multicomponent structure termed the spliceosome, which 
87 
has a sedimentation coefficient of approximately 40-60S (Brody and Abelson 1985; Fren-
dewey and Keller 1985 and Grabowski et al., 1985). The formation of the spliceosome is 
necessary for the splicing reaction, and its assembly requires the presence of appropriate 
splicing signals in the pre-mRNA. 
A major aspect of research in pre-mRNA splicing is the identification and determi-
nation of the function of the splicing machinery. It is now clear that at least five snRNPs 
(U1, U2, U4, U5 and U6), are involved in splicing of both yeast and higher eukaryotic 
pre-mRNAs (Guthrie and Patterson 1988; Maniatis and Reed 1987; Steitz et al., 1987). An 
ordered pathway for the assembly of the spliceosome has been deduced (Cheng and Abel-
son 1987; Konarska and Sharp 1986; Konarska and Sharp 1987; Lamond eta!., 1988; 
Pilkielny et al., 1986). U1 binding to the pre-mRNA occurs first, and this is followed by 
the binding ofU2, U4, U5 and U6 snRNAs (Bindereif and Green 1987Ruby and Abelson 
1988). The snRNP-mediated steps in splicing range from direct base pairing interactions 
between the snRNAs and intron sequences (Parker et al., 1987; Seraphin et al., 1988; 
Zhuang and Weiner 1986); to interactions co-ordinated by protein factors (Ruskin et al., 
1988; Tazi et al., 1986). At least one hnRNP protein is associated with mammalian 
spliceosomes and is also required for in vitro splicing (Choi et al., 1986; Sierakowska et 
al., 1986). 
Studies on pre-mRNA splicing inS. cerevisiae can take advantage of the extensive 
genetic and molecular approaches that are available for the identification and characteriza-
tion of mutations in the splicing pathway (reviewed in Vijayraghavan and Abelson 1988; 
Warner 1987). An important aspect in the genetic analysis of splicing in yeast has been the 
availability of a set of temperature sensitive mutations in the genes RNA2 through RNAJJ . 
By general consensus among the community ofresearchers working on RNA processing in 
yeast and the yeast genetic stock center, these mutants will be called Qre-RNA Qrocessing 
(prp ) mutants. These genetic candidates for the components of the splicing machinery 
have been used in in vitro biochemical studies. These experiments have demonstrated the 
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direct participation of many of the PRP2-11 gene products in the pre-mRNA splicing pro-
cess (Lustig eta/., 1986). Splicing activity in extracts prepared from the prp 2, 3, 4, 5, 7, 
8 and 11 strains are heat sensitive in vitro . The loss of activity was shown to be due to the 
inactivation of an exchangeable component in each case by in vitro complementation of 
pairs of inactivated extracts. Except for PRP2 the PRP gene products 3, 4, 5, 7, 8 and 11 
are required for the assembly of the spliceosome (Lin eta/., 1987). Molecular characteri-
zation of some of the cloned PRP genes has indicated that they code for proteins (Jackson 
et al., 1988; Last eta/., 1984; Lee eta/., 1984; Slotyk et al., 1984). Antibodies directed 
against PRP8 fusion proteins inhibit in vitro splicing reactions and these antibodies have 
been used to detect an association of the PRP8 protein and the yeast U5 snRNA (Lossky et 
a/., 1987). In the case of PRP 11 the 35s-labeled protein was shown to associate with the 
40S spliceosome and to also associate with a 30S complex (Chang eta/., 1988). The role 
of the other PRP gene products are being investigated in several laboratories. 
A combination of genetic and biochemical techniques is therefore proving to be ex-
tremely useful in the identification of pre-mRNA splicing factors. About 5% of the original 
Hartwell bank of temperature sensitive lethals have now been shown to lead to defects in 
splicing, thereby suggesting that a large number of genes are involved. The need for a 
number of trans-acting factors in pre-mRNA splicing is also apparent from the complexity 
of the spliceosome and the pre-mRNA splicing process. To isolate more mutants defective 
in pre-mRNA splicing we have constructed a bank of ts yeast strains by chemical mutagen-
esis. The mutant bank has been directly screened for pre-mRNA processing defects by a 
Northern blot assay. Genetic characterization including complementation and segregation 
analysis has been conducted for all the candidates. The screen of about 1000 ts lethals has 
resulted in the identification of several new complementation groups. Some of these new 
complementation groups show novel phenotypes, implying a role for these gene products 
in various steps of the splicing pathway. 
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RESULTS 
Generation of a bank of ts lethals in S. cerevisiae : We chose the parent strain 
for mutagenesis on the basis of the presence of suitable markers for genetic manipulations, 
and our ability to use extracts prepared from the parental strains for in vitro splicing as-
says. This feature is important for the subsequent analysis of mutants in the in vitro splic-
ing system. About a thousand ts strains were isolated by ethyl- methanesulfonate (EMS) 
mutagenesis, followed by replica plating on rich medium to screen individual mutagenized 
yeast colonies for mutants able to grow at 230C, but unable to grow at 37°C. The wild 
type parental strain grew at both temperatures. The dose of EMS and time of mutagenesis 
were selected to give between 10 to 30% survival after mutagenesis. The ts lethals repre-
sented about 1-2% of the survivors. The mutagenesis was done on a pair of congenic 
strains of opposite mating types resulting in the isolation of half of the ts bank of one mat-
ing type and the second half in the other. Most of the mutants are expected to be of inde-
pendent origin obtained from several batches of mutagenesis. 
Screening of mutants: We have employed a direct assay of screening the mutants for 
the presence of intron- containing transcripts, not normally seen in a wild type cell (Fig. 
1A). The prp2-ll complementation groups proved to be controls for the development of a 
screen that could reproducibly obtain such pre-mRNA splicing mutants. They were used 
as standards in developing conditions for the temperature shift, RNA preparations and the 
detection of intron-containing transcripts. Early to mid log phase cells from individual ts 
strains grown at permissive temperature (230C) were shifted to non-permissive tempera-
ture (37°C) for two hours, and harvested. Analysis of the RNAs, present at non-permis-
sive temperature, was done after a rough estimation of total RNA. Approximately equal 
amounts of total RNA were fractionated on agarose gels, and were subsequently blotted 
onto nylon filters. Two features of the effects of prp2-ll mutations on RNA processing 
are evident. First the unique presence of intron-containing precursors after temperature 
90 
shift and second, a decrease in the processed mRNA levels. The levels of mRNA are de-
creased to 10% to 50% of the levels in wild type cells (data not shown). We therefore 
chose on the criterion of accumulation of pre-mRNA as an indicator of RNA processing 
defects, a feature common to all the prp2-11 complementation groups. 
These filters were then probed for pre-mRNA with 32p labeled actin intron se-
quences. The actin transcripts were probed for the following reasons. Firstly actin is an 
abundant mRNA, and secondly, actin pre-mRNA is efficiently processed and no pre-
mRNA or intermediates of RNA processing are detectable in wild type cells (this study). 
This is in contrast to another intron-containing transcript, that from the CYH2 locus, in 
which even wild type cells show readily detectable amounts of pre-mRNA (data not 
shown). In addition, in order to obtain a clear result for splicing defects, the blots were 
probed with a labeled fragment from the actin intron. This probe allows the detection of 
pre-mRNA, lariat intermediate, and the released intron, all of which are not found in wild 
type cells (Fig. lB). The detection of intron-containing RNA species is indicative of a 
mutant phenotype. 
Several positives that accumulate intron containing RNAs to varying levels were 
found (Fig. 2). Of the 1000 ts mutants screened, 36 mutants were candidates for defects in 
pre-mRNA processing and were chosen for re-screening. All candidate strains from the 
primary screen were then colony purified and re-tested for in vivo ts lethality. Subse-
quently, total RNAs were prepared from these strains, grown at both permissive and non-
permissive temperature, for northern analysis. Most of the newly isolated mutants showed 
a temperature dependent accumulation of pre-mRNA (Fig. 2A lanes c and d; e and f; i and j 
). However, in some cases a splicing phenotype is evident even at the permissive temper-
ature (Fig. 2 lanes g and h). In these cases there exists a possibility of having generated 
two independent mutations, one affecting the RNA processing and another leading to the ts 
lethality. The splicing phenotype in most mutants is consistent with pre-mRNA accumula-
tion, except for distinct phenotypes observed in the following mutants. ts a 107 appeared 
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to accumulate both the pre-mRNA and intron for actin transcripts (data not shown). ts a 
319 appeared to have a pleitropic effect on pre-mRNA processing at non-permissive tem-
perature: both pre-mRNA and an intron-containing transcript larger than pre-mRNA accu-
mulated (Fig. 2A, lane d). Mutants containing RNA of mobility corresponding to that of 
the released intron were readily apparent even at the primary screen; these strains did not 
show any accumulation of pre-mRNA (Fig. 2A, lanes a and b). 
Separation of the lariat intermediate from the pre-mRNA for actin transcripts is not 
sufficiently reproducible in these gels to distinguish between these two species of RNA 
(pre-mRNA being 1.7 kb; lariat intermediate being -1.5 kb). Mutants that accumulate lariat 
intermediates specifically, could be identified through primer extension analysis of the 
RNAs (see below). The levels of mRNA after temperature shift are reduced in all but one 
of these prp mutants consistent with the appearance of pre-mRNA (Fig 2B, lanes c, d, e, 
f, g, h, i and j). There is no change in mRNA levels observed for the mutant exhibiting 
accumulation of the intron (Fig.2B, lanes a and b ). 
If the mutations isolated by this screen affect the cellular splicing machinery, intron-
containing transcripts other than actin would be expected to accumulate. This was tested by 
probing northern blots for a second intron-containing transcript -RP59 . As expected an 
increase in pre-mRNA or the lariat intermediate was observed together with a dramatic de-
crease in the level of the mature mRNA at non-permissive temperature (data not shown). 
All of these mutants were specific for their effect on pre-mRNA, as non-intron-containing 
transcripts from the TCMl, PABl and STE2loci did not accumulate (M.Aebi per. comm.). 
Primer extension analysis : In order to map precisely the 5' ends of the accumulated 
RNAs, primer extension analyses were conducted. These experiments would clearly dis-
tinguish between mutants that specifically accumulate the pre-mRNA from those which ac-
cumulate the lariat intermediate. An oligonucleotide primer, complementary to the se-
quences in the RP51A intron 70 bases downstream of the 5' splice site (For RP51A se-
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quence see Teem and Rosbash (1983)) was used for primer extension. Total RNA pre-
pared from cells at both permissive and non-permissive temperature were used. In wild 
type cells a very low level of the extension products corresponding to the pre-mRNA or the 
lariat intermediate of RP51A was observed (Fig. 3A, lanes a and b). In the prp mutants ts 
a 47, ts a 107, ts a 449, ts a 514 ,ts a 87 and ts a 344 , an increased levels of pre-mRNA 
is seen upon temperature shift (for example Fig. 3A, lanes g and h). Two primer extension 
products corresponding to pre-mRNA were obtained, representing RNAs initiated from 
the two transcription start sites of RP51A (Teem and Rosbash 1983). An increased level of 
the lariat intermediate is seen at permissive temperature in some of the strains that accumu-
late pre-mRNA at non-permissive temperature. This could be indicative of low splicing ef-
ficiency even at permissive temperature. 
In the strains ts a 452 , ts a 503 , ts a 365 and ts a 487 , only a single extension 
product corresponding to the 5' end of the RP51A intron is detected (For example Fig 3A, 
lanes e and f). These strains had exhibited accumulation of large, intron-containing actin 
transcript ( -1.5kb , Fig. 2A, lanes g and h) on northern blots. To verify that this -1.5 kb 
actin RNA represented the lariat intermediate of actin, primer extension experiments were 
done with a oligonucleotide primer complementary to the actin intron sequences 70 nts 
downstream of the 5' splice site. A dideoxy sequencing experiment, using the same 
primer, on an actin M13 clone allowed a precise mapping of the 5' splice site. These ex-
periments confmn the accumulation of the lariat intermediate of the actin transcript (Fig. 
3B, lanes d and e). The primer extension experiment with RP51A transcripts and actin 
transcripts indicated that in these mutants there is no increase in the level of full length pre-
cursor. This suggests that, in these mutants, the first step of splicing : cleavage at the 5' 
splice site proceeds normally, but the second step of splicing is defective. This phenotype 
is evident at both permissive and non-permissive temperature and does not affect the preci-
sion of cleavage at the 5' splice site. These results also confmn that the primary defect in 
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these strains is accumulation of the lariat intermediate of splicing with no effect on the lev-
els of the pre-mRNA. 
The mutants ts a 278, ts a 391 , ts a 45 and ts a 397, accumulate the released 
intron specifically (Fig. 2A, lanes a and b). Primer extension again demonstrate a 5' ter-
minus in these accumulated RNAs corresponding to the 5' end of the intron. ( For example 
Fig3A, lane c and d; Fig 3B lanes b and c) The accumulation of the intron was observed at 
both permissive and non-permissive temperature. Reverse transcription with an oligonu-
cleotide that hybridizes 3' to the branch consensus of RP51A or actin indicates that these 
molecules are branched at the correct site and therefore do not represent imprecisely spliced 
or branched molecules (data not shown). 
Complementation analysis: The mutants picked by this screen were back-crossed to 
the appropriate congenic wild type strain of the opposite mating type and heterozygous 
diploids were obtained. The putative diploids were tested for diploidization and for the ts 
phenotype. All diploids were temperature resistant implying that in all these strains the ts 
loci were recessive. No dominant ts mutants were isolated in this screen. In order to de-
fine which of the newly isolated mutants belonged to known complementation groups, each 
mutant strain was crossed to prp2 through 11 mutants of the opposite mating type, and the 
diploids were isolated on the appropriate selective media. The diploids were subsequently 
screened at permissive and non-permissive temperature. Non-complementing diploids ex-
hibit a ts phenotype and thus show that the pair of recessive mutants belong to the same 
complementation group (Fig 4). The complementation analysis showed that six mutants 
were prp2 , seven were prp3 , six were prp6 and two were prp9 . No new isolates of 
prp4, 5, 7, 8 or 11 were obtained (Table 1). Mutants that complement the prp2-ll (all 
pairs of diploids are ts + ) were taken to represent new complementation groups (see Table 
1). ts a 100, a mutant that accumulates pre-mRNA, had a mating defect and hence has not 
been assigned to any group. We now assign all the new mutants to complementation 
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groups. First, the MA Ta and MAT a mutants were crossed. We determined that the mu-
tants ts a 452 , ts a 503 and tsa 49Jbelong to the same complementation group. For the 
remaining mutants, which were in one mating type, corresponding mutants of the opposite 
mating type were constructed. We then crossed the Mat a mutants with Mat a mutants and 
assigned complementation groups. All of these complementation results are based on the 
assumption that in these mutants the ts defect and the splicing phenotype were being caused 
by a mutation in the same gene. In our segregation analysis (see following section) two 
complementation groups were represented by non-ts alleles (Table 1). Re-affirmation of 
their complementation group assignment was made after analysis of the RNA for the splic-
ing phenotype in the appropriate diploids. Table 1 summarizes the results of the comple-
mentation analysis. We find eleven new complementation groups. These groups can be 
divided into four phenotypic classes: 1) six complementation groups that accumulate pre-
cursor, 2) two complementation groups that accumulate lariat intermediate; 3) two comple-
mentation groups that accumulate the released intron; and 4) one complementation group 
that accumulated both pre-mRNA and intron . 
Segregation analysis: Mutants that complement prp2 -11 were analyzed further to de-
termine if single-site mutations were responsible for splicing phenotype and the temperature 
sensitivity. The diploids that were heterozygous for a prp mutant were sporulated. Tetrad 
analysis showed that in all cases the ts defect segregated 2:2 (ten to twenty tetrads analyzed 
in each case), as did all other heterozygous markers, indicating a defect in a single nuclear 
gene. Co-segregation of the splicing phenotype with the ts defect was also analyzed for 
all the new complementation groups. RNA from several tetrads (in each case six to nine 
tetrads) and from the heterozygous diploid were analyzed after temperature shift on north-
ern gels ( Fig. 5 panels A, B, C and D). Appearance of the splicing defect in the ts spores 
is indicative of co-segregation of the two phenotypes. The heterozygous diploids did not 
display a gene dosage effect for both the ts andprp phenotype (data not shown). Co-seg-
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regation was observed for the precursor accumulating strains ts a 47 (Fig. 5a), ts a 107 
(Fig. 5b ), ts a 319 , ts a 514 , tsa 87 and ts a 344 . The lariat intermediate accumulating 
mutants ts a 503 (Fig. 5c) and ts a 365 -representing the two complementation groups-
also displayed co-segregation of the splicing and ts phenotype. 
Among the intron-accumulating mutants only one ts a 397 (Fig. 5d), exhibited co-
segregation of the splicing and ts phenotypes. The accumulation of intron in the strains ts a 
278, ts a 391 and ts a 45 was caused by a single nuclear recessive gene but was not linked 
to the ts defect. This result implied that the four isolates of the intron- accumulating mutant 
possibily represent one complementation group with ts and non ts alleles. Diploids ob-
tained from crosses of each of the intron mutants to all the others and also to all the splicing 
mutants were analyzed for the presence of the intron phenotype at non-permissive temper-
ature. Intron accumulation phenotype was observed only in diploids obtained from pair-
wise crosses using ts a 278, ts a 391 and ts a 45 . These results indicated that the intron 
mutants ts a 278, ts a 391 and ts a45 represent one new complementation group and the 
mutant ts a 397, another (Table 1). 
The precursor accumulation in the mutants ts a 449 and ts a 377 was not linked to 
the ts lethality, and the isolation of these mutants as ts was just serendipitous. An analysis 
of the RNA in diploids similar to that done for the intron mutants was conducted. These 
results indicated that the mutant ts a 449 represented a new complementation group and is 
not a non-ts allele of another complementation group. On the other hand ts a 377 proved 
to be a non-ts allele of prp2 , a previously known complementation group. 
DISCUSSION 
The enumeration, identification and determination of function of the splicing componentsis 
essential for the complete understanding of the pre-rnRNA splicing process. The complex-
ity of the spliceosome is revealed by biochemical work indicating the involvement of five 
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snRNPs (Ul, U2, U4, U5 and U6), hnRNPs and several protein factors. The extensive 
repertoire of genetic techniques applicable to the yeast Saccharomyces cerevisae allows the 
combined approach of biochemistry and genetics in analysis of pre-mRNA splicing in 
yeast. Analysis of the yeast mutants in 10 complementation groups (prp2-11) over several 
years has made it clear that primary defect in these strains is the accumulation of intron 
containing pre-mRNAs at non-permissive temperature (Miller 1984; Rosbash eta/., 1981; 
Teem et a/., 1983). The direct participation of many of these gene products comes from 
demonstration in vitro that seven of these complementation groups can be specifically heat 
inactivated. Further work on these mutants in both in vitro and molecular characterization 
of the wild type loci been of tremendous value in understanding splicing. 
Our direct screening of a temperature sensitive bank of yeast strains for splicing 
mutants has resulted in the isolation of four classes of mutants affecting different stages of 
the splicing reaction pathway. The major class of six new complementation groups share 
the phenotype of the prp2 to 11 groups (pre-mRNA accumulation). Two novel classes af-
fecting late events in splicing were obtained. One class accumulates the lariat intermediate 
of splicing and the other accumulates the released lariat intron, with no significant increase 
of the pre-mRNA. One mutant was obtained that could be classified as both a pre-mRNA 
and an intron-accumulating strain. Such a phenotype could result from the lack of recy-
cling of a early-acting splicing component. The association of such a component with the 
released intron, after splicing, could account for the stabilization of the intron. 
New ts mutations define genes involved in various stages of pre-mRNA 
splicing: The prp2-11 mutants were initially identified as being defective in RNA 
metabolism and their isolation was not due to a specific screen for mutants in pre-mRNA 
splicing (reviewed in Vijayraghavan and Abelson 1988; Warner 1987). Of the initial col-
lection of ts lethals generated by nitrosoguanidine mutagenesis about 5% of the mutants 
were defective in splicing (Hartwell eta/., 1970). We have screened our ts bank specifi-
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cally for identification of mutants in pre-mRNA splicing. The screening of the ts mutants 
for the presence of intron-containing transcripts was a rational approach because all of the 
previously identified complementation groups (prp2 to 11 ), shared the phenotype of pre-
mRNA accumulation at non-permissive temperature. We have isolated 36 mutants defec-
tive in pre-m.RNA splicing that represented both old and new complementation groups. 
The majority of the new complementation groups shared the same phenotype of 
pre-m.RNA accumulation as seen in the prp2-11 mutants. These mutants presumably act 
early in splicing. One complementation group displayed a pleiotropic effect on mRNA 
processing. The presence of intron-containing transcripts larger than the pre-mRNA was 
seen for both actin and RP59. Further analysis of this mutant phenotype would be essen-
tial to determine the primary defect in this strain. The isolation of a large number of com-
plementation groups affecting the early steps of the splicing pathway could be due to the 
requirement for several factors early in spliceosome assembly. These could range from 
components that are direct participants in the splicing machinery, to components that per-
form essential modifications of the spliceosomal components, or to components of hnRNP 
complexes and factors involved in only the assembly of the spliceosome and not in later 
functions of the spliceosomes. An alternative reason could be the presence of shared com-
ponents between the early and late steps of the splicing pathway. 
The identification of pre-mRNA processing mutants by this approach does not 
seem to be limited to those that can be isolated as ts alleles alone. From our ts bank we 
have isolated one new complementation group that accumulates pre-mRNA, but results in 
a splicing defect without a severe growth defect at 370C. The explanations for this phe-
notype are unclear. In addition we have obtained mutants (discussed below) that accumu-
late intron, but are not ts, and also a non-ts allele of a previously identified mutant-prp2 . 
Not all of the rna 2-11 complementation groups were represented in this screen of 
EMS induced ts mutations. However, there exists a similarity in the distribution of allele 
numbers in the prp2 , prp3 and prp9 groups between this and the previous study (Harwell 
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et al., 1970) . In both cases a significantly higher number of prp2 and prp3 alleles were 
obtained than alleles in other complementation groups. One difference is the higher fre-
quency of isolation of prp6 in this study. prp7, prp8 and prpll were represented by single 
isolates in the Hartwell screen and no alleles of these mutants were picked up in this screen. 
This might be reflected in the number of mutants screened (-1000) after our moderate mu-
tagenesis compared to the screen of the heavily mutagenized bank ( 400). 
The direct screen employed has also obtained new complementation groups that af-
fect late events of splicing. Four complementation groups exhibit novel phenotypes of lar-
iat intermediate or intron accumulation . The Hartwell screen employed for the isolation of 
the prp2-ll mutants was based on the ratios of protein/RNA incorporation being >4, hence 
it is not unexpected that no mutants that accumulate intron were obtained ( ). The levels of 
mRNA, and hence protein synthesis in the intron-accumulating mutants is probably unaf-
fected within two hours of temperature shift. The isolation of these new complementation 
groups in our search for splicing mutants might be an effect of both the direct screen em-
ployed and the mutagen used. 
Trans-acting ts mutations result in lariat intermediate accumulation : The 
isolation of mutants with a novel phenotype affecting only the second reaction of splicing 
allows an opportunity for the investigation of factors required specifically after the spliceo-
some assembly and the first step of splicing. Two complementation groups with this phe-
notype have been obtained. All mutants in these groups are temperature sensitive. The 
precision of the 5' splice site and the branch point selection is not affected and utilization of 
the wild type 5' splice site and branch formation site is observed. No change in the levels 
of the pre-mRNA occurs; hence, the effects seem to be specific for the second step of 
splicing and the presence of the lariat intermediate in splicing is probably not due to slower 
splicing. The alleles are partly defective at permissive temperature and show increased lev-
els of the lariat intermediate. The second step of splicing leading to formation of mRNA 
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and lariat intron takes place, although inefficiently, at permissive temperature. A substan-
tial decrease in second splicing reaction and hence the mRNA levels takes place upon tem-
perature shift. 
These are the only trans-acting mutants known to act in the splicing pathway after 
the 5' splice site cleavage has taken place. From the previous studies on the analysis of the 
spliceosome assembly, one expects an accumulation of the active spliceosome containing 
the exon1 and the lariat intermediate (Cheng and Abelson 1987; Pik:ielny eta/. , 1986). 
None of the prp2-ll mutants undergo any of the splicing reactions and most are required 
early in spliceosome assembly (Lin eta/., 1987). Of the prp2-ll mutants, the PRP2 gene 
product is the only one known to be required after the formation of a late intermediate of 
spliceosome assembly (Lin et al., 1987). Heat inactivation experiments with prp2 had 
demonstrated the accumulation of spliceosomes containing the pre-mRNA with both steps 
of splicing blocked. The newly defined complementation groups that accumulate the lariat 
intermediate must represent gene products that act after PRP2 in the spliceosome assembly 
pathway. Chasing experiments with heat inactivated prp2 spliceosomes have led to the 
proposal that two distinct sets of factors are required for the second step of splicing reac-
tions (Lin et al., 1987 ). One of these factors, fraction III, had been identified earlier 
through fractionation of wild type extracts (Cheng and Abelson 1986). The second set of 
factors termed Cn comprise an unidentified set of factors. The ts mutations in two comple-
mentation groups accumulating the lariat intermediate possibly result from mutations in one 
of these factors predicted to act late in the splicing pathway. 
Stabilization of the released intron: Apart from the isolation of mutants required for 
the second step of splicing, new complementation groups were obtained with novel phe-
notype identifying gene products required after splicing has been completed. The pheno-
type of intron accumulation was observed in two complementation groups. One group is 
represented by a single allele and is ts , while the other consists of three alleles and none of 
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them are ts (Table 1). Wild type cells appear to degrade the intron very rapidly, with no 
detectable amount of the released intron in the cells. The accumulation of the intron implies 
that it must be stabilized. The intron-accumulating phenotype does not result from the ac-
cumulation of aberrantly formed lariats due to the imprecise utilization of the 5' splice site 
or the branch acceptor nucleotide (Fig. 3). The stabilization of the intron could result from 
its association with spliceosomal components due to a defect in the disassembly, or from a 
defect in the debranching function itself. Analysis of the biochemical phenotype should 
lead to a better understanding of the nature of these mutations. An additional mutant (ts 
107 )shows accumulation of both pre-mRNA and some intron. It probably results from a 
mutation in a factor required early in splicing. The accumulation of intron in this mutant 
may result from the continued association of this factor with released intron. Altenatively, 
this mutation may somehow affect the recycling of spliceosomal factors after the release of 
the intron. 
Isolation of new alleles of prp2, prp3 , prp6 and prp9 : The 21 new alleles cor-
responding to the previously identified complementation groups (prp2-11) were identified 
solely on the basis of complementation of the ts or prp phenotype in the diploid. In multi-
component systems, like pre-mRNA splicing, the possibility that the ts or the prp pheno-
type in the diploid is due to unlinked, non-complementation needs to be considered (for 
example Atkinson 1985; Stearns and Botstein 1988). Thus, it is possible that some of the 
mutants now thought to be in the prp2 -11 complementation groups could actually represent 
new mutations in components interacting with the PRP 2-11 gene products. This ques-
tion can easily be addressed genetically through the recombination analysis of spores from 
temperature sensitive diploids. The isolation of any non-complementing unlinked mutants 
would be extremely interesting as these mutants might define components that interact with 
PRP2, 3, 6 and 9 gene products. These mutations resulting in pre-mRNA accumulation, 
could define components that are themselves a part of the splicing machinery. 
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The assignment of ts a 100 , ts a 200 to the prp9 complementation group is 
tentative since it is uncertain that the original prp9-1 mutation was due to a single site ts 
mutation (Hartwell eta!., 1970). Confirmation of the assignment of the putative prp9 alle-
les should be easily done once the genetic analysis of the originalprp9-l allele is complete. 
In conclusion, we have isolated more splicing mutants affecting various stages of 
the splicing pathway. Of these, a few complementation groups (prp2, prpl7, prpl8, prp25 
and prp26) specifically affect splicing after the spliceosome assembly. The isolation of 
multiple alleles in some of these groups suggests that few components are required specifi-
cally for the later stages of splicing. Two avenues of research are now open to further 
characterize the new mutants. The co-segregation of the prp and the ts phenotype provides 
a good oppurtunity to study the function of these gene products through rapid molecular 
cloning. In parallel, the in vitro characterization of the mutants would also be useful in 
giving a more detailed understanding of these phenotypes. Both of these complementary 
approaches are easily achieved in yeast with the existence of in vitro systems and the 
extensive molecular genetic techniques. 
Footnote: The genetic designation of the rna2-ll mutants isolated by Hartwell eta!. 1970 
is being changed by a general consensus among the yeast RNA processing community to 
prp for .Q_re-RNA .Q_rocessing. This nomenclature would clarify that these prp (rna) mutants 
are different from the small nuclear RNAs that also play an essential role in pre-mRNA 
splicing. Most of the prp (rna ) that have been analyzed code for protein components of the 
splicing machinery. 
MATERIALS AND METHODS 
Yeast strains: Table 2 lists the strains used in this study. The source of these strains is 
described in Lustig et al., (1986). 
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Genetic manipulations: The media, rich (YPD), omission, presporulation and sporu-
lation were prepared as described in Sherman eta/., (1986). Complementation analysis 
was carried out by mixing pairs of rna mutants of opposite mating type on YPD plates and 
allowing mating and diploid growth at 230C overnight. The diploids were obtained from 
minimal plates supplemented for their selection . The diploids were then tested for growth 
at 37oc on YPD plates. In cases where necessary, complementation of the rna phenotype 
in the diploids was assessed by northern analysis. Diploids for the analysis of dominant vs 
recessive nature were obtained at permissive temperature from selective media. Sporulation 
of the heterozygous diploids was done at 230C and dissection of spores was done by stan-
dard procedures also at 23oc. 
Mutagenesis: The two strains, wild type for growth at 370C : SS330 and SS328 were 
mutagenized with the alkylating agent ethylmethanesulfonate (EMS) essentially as in Moir 
eta/., (1982). Stationary phase cells were resuspended at 108 cells/ml in 0.1M sodium 
phosphate buffer pH7.0 and were treated with 3% EMS for about 60 minutes. This treat-
ment was calibrated to give 10-30% survival for these strains after the procedure. Mutage-
nized cells were first diluted 40-fold in sterile 5% sodium thiosulfate to inactivate the muta-
gen. This was followed by dilutions in sterile water and plating for growth on YPD plates 
at 23°C. Plates with -200 colonies were replica plated on pre-warmed YPD plates and left 
overnight at 37°C. Colonies that grew poorly or did not grow at 370C were retested for 
the growth defect and the strains that still exhibited poor or no growth at 37oc were in-
cluded in the temperature sensitive strain collection. 
Temperature shift and preparation of RNA: Each of the ts mutants was grown in 
a 2ml. YPD culture to early-to-mid log phase of growth (A600 0.5 to 2.0) and then shifted 
to non-permissive temperature 37°C for two hours. Cells were pelleted and then frozen in 
dry ice. As a control for the temperature shift experiment either a prp2 or a prp5 strain was 
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used as a control. Extraction of the total RNA from the cell pellet was done by the method 
of hot phenol extraction similar to that of Domdey et al., (1984). Cell pellets were resus-
pended in 50rnM NaOAC pH5.3, lOrnMEDTA vortexed and SDS was added to 1%. The 
cell suspension was vortexed and extracted with phenol (equilibrated with 50rnM NaOAc 
10rnM EDTA) at 650C for five minutes. Following centrifugation the aqueous phase was 
transferred and extracted with equal volume of phenol:chloroform:: 1: 1, at room temperature 
for five minutes. After centrifugation the aqueous phase was brought to 0.3M NaOAC and 
the RNA precipitated with 2.5 to 3 volumes of ethanol. The RNA yield was usually 50-
200 micrograms from this small scale prep. Rescreening of the positives from the frrst 
screen was done at both temperatures. Here an aliquot of the mid log phase cells was 
shifted to non-permissive temperature for two hours and the rest of the culture maintained 
at permissive temperature. Extraction of RNA was done as described above from both 
cultures. 
Northern analysis: Approximately 10 micrograms of total RNA from each mutant at 
non-permissive temperature was used for northern analysis on formaldehyde-agarose gels. 
The RNA was added to formamide dye mix (50% formamide, 6%formaldehyde, 50rnM 
HEPES pH7 .4, 1 rnM EDT A, 20% glycerol and 0.1% of the dyes bromophenol blue and 
xylene cyanol) and heated at 65C for two minutes before loading on gels. The elec-
trophoresis was done in 1.2% agarose gels in 50mM HEPES 1rnM EDTA 6% formalde-
hyde. Following electrophoresis the RNA was blotted on to Gene-Screen membranes in 
25rnM sodium phosphate pH6.5. The RNA was cross-linked on the membranes as de-
scribed in Cheng and Abelson (1987). 
Prehybridization, hybridization and washing of the filters was done as described in 
Cheng and Abelson (1987). The blots were probed with a -200 bp fragment of the actin 
intron (Xhoi to Clai of actin intron), labeled by the random primer extension method of 
Feinberg and Vogelstein (1983) and used for the detection of the pre-mRNA, lariat inter-
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mediate and the intron. The detection of the mRNA and the pre-mRNA was done with the 
labeled fragment of the actin clone. Repro bing of the blots was done after removal of the 
probe by boiling in 0.1x SSC, 0.1%SDS for 5-10 minutes. 
Reverse Transcription : Oligonucleotides used for the primer extension were as given 
below: 
RP51A-27: 5' GTATGACfTTATIGCGCATGTCGACfC 3' 
Actin Xhol : 5' CfCfCGAGCAA TIGGGACCGTGC 3' 
The primer oligonucleotides (20ng) were 5' end labeled using gamma 32p A TP ( crude 
7000Ci/mM) and T-4 polynucleotide kinase. The labeled oligonucleotides were purified on 
DE-52 ion exchange column, and ethanol precipitated. 20-25 micrograms of total RNA 
was used in each primer extension with -50,000 cpm of the primer in 50 mM Tris HCl 
pH8, 150 mM KCl, 0.5 mM EDTA, 1 mM DTI, 7 mM MgCl2. Annealing was done by 
heating the RNA, primer and buffer at 9QOC for two minutes followed by slow cooling to 
room temperature. Fifteen to twenty units of AMV reverse transcriptase and 0.5 mM of 
each deoxynucleotide was added and the extensions done at 420 C for 45 minutes. The 
extension products were separated on 8 or 10% polyacrylamide gels containing 8M urea. 
In cases where dideoxy sequencing was done, a clone of actin in M13 was used as the 
template with the actin oligonucleotide as a primer. The sequencing reactions were per-
formed with a kit from Pharmacia. 
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TABLE 1 
Complementation Number of Splicing Transcripts 
group alleles defect tested 
prp (rna)2 6 pre-mRNA Actin 
prp (rna)3 7 pre-rnRNA Actin 
prp (rna)6 6 pre-rnRNA Actin 
prp (rna)9 2 pre-rnRNA Actin 
prp (rna)l7 1 Lariat-intermediate Actin, RP51A 
(ts 365, ts 487) 
prp (rna)l8 3 Lariat -intermediate Actin, RP51A 
(ts 452, ts 503, ts 491) RP59 
prp (rna)l9 1 Lariat-intermediate Actin, RP51A 
(ts 89) 
prp (rna)20 1 pre-mRNA and Actin, RP59 
(ts 319) transcript larger 
than pre-mRNA 
prp (rna)2l 1 pre-mRNA Actin, RP51A 
(ts47) RP59 
prp (rna)22 1 pre-mRNA and Actin, RP51A 
(ts 89) intron RP59 
prp (rna)23 1 pre-rnRNA Actin, RP51A 
(ts 514) RP59 
prp (rna)24 1 pre-mRNA Actin, RP51A 
(ts 344) 
prp (rna)25 la pre-mRNA Actin, RP51A 
(ts 449) RP59 
prp (rna)26 3a intron Actin, RP51A 
(ts 278, ts 391) CYH2 
( ts 45) 
prp (rna)27 1 intron Actin, RP51A 
(ts 397) 
a --- None of the alleles are ts 
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MATa ade2-101 his3Ll200 lys2-801 ura3-52 
MATa ade2-101 his3Ll200 tyrl ura3-52 
MATaprp(rna)l-1 adel ade2 his7 tyrl ural 
MATa prp(rna)2 leu2-3 leu2-112 ura3-52 
MAT a prp(rna)3 his3 leu2 lys2 ura3-52 
MATa prp(rna)4 his3L1-l leu2-3 leu2-112 lys2 tyrl ura3-52 
MATa prp(rna)5 ade his7leu2 lys2 
MATaprp(rna)6-l adel ade2 his7lys2 tyrl ural 
MATaprp(rna)7-l adel ade2 his7lys2 tyrl ural 
MATaprp(rna)B-1 adel ade2 his7lys2 tyrl ural 
MAT a prp(rna)9 -1 adel ade2 his7 lys2 tyr 1 ural 
MATa prp(rna)ll his4-512 leu2 ura3-52 
MAT a prp(rna)l ade his met trp ura 
MATaprp(rna)2 ade2-l his3-532 trpl-289 ura3-l ura3-2 
MATaprp(rna)3 ade leu 
MATaprp(rna)4 adel ade2 his7leu2 lys2 ura3-52 
MATaprp(rna)5 his3 his7leu2 ura3-52 
MATaprp(rna)6 his3 lys2 ura3-52 
MAT a prp(rna)7 ade arg leu ural 
MATaprp(rna)B ade arg trp ural 
MAT a prp(rna)ll ade his leu lys tyr ura 
113 
FIGURE LEGENDS 
Fig. lA. Scheme used for the isolation of splicing mutants. 
Fig. lB. A representative northern blot from a primary screen of twenty five ts mutants. 
lO!J.g of total RNA from each mutant strain, after two hours at non-permissive temperature, 
was run on a formaldehyde-agarose gel and then blotted. The probe used was a labeled 
fragment of the actin intron. The last lane had total RNA from prp (rna) 2, a strain known 
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Fig. 2 Re-screening, at both permissive and non-permissive temperatures, of some posi-
tives obtained from the primary screen. For each candidate lOJ..Lg of total RNA from cells at 
23°C or after a two hour shift to non-permissive temperature (370C) was analyzed. RNA 
from wild type cells and from prp (rna)5 at both temperatures was also analyzed as con-
trols. The blots were probed in panel A with a fragment of the actin intron and in panel B 
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Fig. 3A Reverse transcription using a primer 5' of the RP51A branch point. 20j.lg of total 
RNA prepared from each of the four different strains denoted above the gel (SS330, ts 45, 
ts 503, ts 514) was used for primer extension. RNA from cells at both permissive and 
non-permissive temperature was analysed as indicated at the bottom of the gel. Schematic 
representations of the two classes of primer extension stops corresponding to 5' ends of 
lariat molecules, or 5' ends of the pre-mRNA are also made. 
3B. Reverse transcription from a primer 5' of the actin branch point. 20j.lg of total RNA 
from the wild type SS330 strain , the mutant ts 391 accumulating the released intron, and 
the strain ts 503 that accumulates the lariat intermediates was used. A schematic represen-




























































































Fig. 4. Complementation analysis of prp mutants. Diploids generated from all pairwise 
crosses of ts 47, ts 87, ts 503, ts 514, prp (rna )2 and the wild type strain. The left plate 
shows growth at permissive temperature (230C) and the right plate the growth of the same 
diploids at non-permissive temperature (370C). Non-complementing diploids exhibit no 
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Fig. 5 Co-segregation of the temperature sensitive and splicing phenotypes. An example 
from each of the four phenotypic classes of splicing mutants was analyzed. Heterozygous 
diploids were sporulated and tetrads dissected in each case. Spores from several tetrads 
were grown to log phase and shifted to non-permissive temperature for two hours before 
RNA extraction. The RNAs were assayed on northern blots for the splicing phenotype. 
Panel A: pre-mRNA accumulation, panel B: pre-mRNA and intron accumulation, panel C: 
lariat intermediate accumulation (IVS-Exon2) and panel D: intron accumulation. The 




















































































































































































































































































A gene product required for the intron-exon2 cleavage and 
ligation of exons 
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ABSTRACT 
We have investigated the role of a novel temperature sensitive splicing mutation prpl8. 
We have previously shown that at the restrictive temperature in vivo an accumulation of the 
lariat intermediate of splicing occurs. We have now used the yeast in vitro splicing system 
to demonstrate that extracts from this mutant strain are heat labile for the second reaction of 
splicing. The heat inactivation of prpl8 extracts results from loss of activity of an ex-
changeable component. Inactivated prpl8 extracts are complemented by heat-inactivated 
extracts from other mutants or by fractions from wild type extracts. In heat inactivated 
prpl8 extracts, 40S splicing complexes containing lariat intermediate and exon1 can as-
semble. The intermediates in this 40S complex can be chased to products by complement-
ing extracts in the presence of ATP. Both complementation of extracts and chasing of the 
isolated prpl8 spliceosomes takes place with micrococcal nuclease-treated extracts. Fur-
thermore, the complementation proflle with fractions of wild type extracts indicates that the 
splicing defect results from a mutation in a previously unidentified factor required for the 
second step of splicing. The isolation of this mutant as a temperature sensitive lethal has 
also facilitated cloning of the wild type allele by complementation. 
INTRODUCTION 
The recognition and splice site selection in nuclear pre-mRNA splicing is dictated by three 
short stretches of sequence elements in the intron (Shapiro and Senapathy 1987). The 
specificity of splice junction selection and the juxtaposition of the exons is achieved by the 
recognition of these cis-acting conserved elements in the intron by cellular factors that in-
clude proteins and small nuclear ribonucleoprotein particles (snRNPs) (reviewed in Sharp, 
1987; Maniatis and Reed 1987). The development of in vitro splicing systems has led to 
considerable progress in the elucidation of the pathway of nuclear pre-rnRNA splicing 
(reviewed in Padgett eta/., 1986; Green 1986). The pre-mRNA is spliced in a large multi-
component structure termed the spliceosome (Brody and Abelson 1985; Frendewey and 
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Keller 1985; Grabowski et al., 1985; Bindereif and Green 1986; Perkins et al., 1986). 
Splicing reactions that take place in the spliceosome occur via a two-step mechanism. First 
the pre-mRNA is cleaved at the 5' splice junction and this results in the formation of a lariat 
intron-exon2 structure in which the first base of the intron is covalently linked to a specific 
adenosine near the 3' splice site. The cleaved exon1 and the lariat intron-exon2 are the in-
termediates of the splicing reaction. The second reaction involves cleavage at the 3' splice 
site and the ligation of the two exons to produce the mature mRNA and the lariat intron. 
The complexity of the splicing reaction and the large particle within which the reac-
tions take place suggests the need for multiple functions. It is now clear that at least five 
snRNPs (U1, U2, U4, U5 and U6), are involved in the splicing of both yeast and higher 
eukaryotic pre-mRNA (Steitz et al., 1987; Guthrie and Patterson 1988). These snRNPs 
have been found to associate with active splicing complexes. The assembly intermediates 
are resolved on non-denaturing gels and they vary in the order of appearance and their 
snRNP composition. U1 binds to the pre-mRNA first and this is followed by the binding 
of U2, U4, U5 and U6 snRNPs (Konarska and Sharp 1986; Pikielny et al., 1986; Cheng 
and Abelson 1987; Bindereif and Green 1987; Ruby and Abelson 1988). The requirement 
in splicing for protein factors, apart from snRNPs, has been demonstrated through bio-
chemical fractionation of splicing extracts (Krainer and Maniatis 1985; Cheng and Abelson 
1986; Kraemer et al., 1987). A role for hnRNP proteins in splicing is also indicated from 
inhibition experiments performed with antibodies against hnRNP core proteins (Choi et al., 
1986; Sierakowska et al., 1986). 
Analysis of splicing factors in yeast can readily employ a combination of biochemi-
cal, classical genetic and molecular approaches. Such an approach has taken advantage of 
the availability of a set of temperature sensitive mutations (rna2 toll ) that affect pre-
mRNA splicing in vivo (reviewed in Warner 1987; Vijayraghavan and Abelson 1988). 
Henceforth all the rna mutants will be called as 12re-RNA J2rocessing: prp mutants. Tem-
perature sensitive strains bearing these mutations when shifted to non-permissive tempera-
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tures accumulate pre-mRNAs (Rosbash et al., 1981; Miller 1984). These mutations were 
the best candidates for the genetic analysis of yeast pre-mRNA splicing components. In 
vitro heat inactivation of splicing extracts from many of these prp complementation groups 
has implied a more direct role for these gene products in pre-mRNA splicing. Consistent 
with the in vivo observation of pre-mRNA accumulation at non-permissive temperature in 
all of the prp 2- 11 strains, inactivation of both steps of splicing was observed upon heating 
of splicing extracts from several groups (Lustig eta/., 1986). In addition, most of the PRP 
gene products have been demonstrated to be required for spliceosome formation itself (Lin 
et al., 1987). The PRP2 gene product acts after spliceosome assembly and is required for 
the first splicing reaction. Studies on the role of PRP2 in in vitro splicing systems have 
proposed the need for several extrinsic and intrinsic factors for both splicing reactions (Lin 
eta/., 1987). Apart from the in vitro characterization of the prp 2-11 mutants, many of 
these genes have been cloned and their molecular characterization has been initiated (Last et 
a/., 1984; Lee eta/., 1984; Soltyk et al., 1984; Jackson et al., 1988; reviewed in Vi-
jayraghavan and Abelson 1988). Antibodies directed against PRP8 and PRP 11 proteins 
inhibit in vitro splicing reactions, reaffirming their essential role in splicing reactions 
(Jackson et al., 1988; Chang et al., 1988). The PRP8 protein has been demonstrated to 
associate with U5 snRNA (Lossky et al., 1987). The PRP 11 protein associates with 
spliceosomes and is also present in a pre-assembled 30S complex. Further analysis of the 
PRP gene products is likely to reveal their precise role in the splicing machinery and deter-
mine if they are homologs of protein factors required in higher eukaryotic spliceosomes. 
Thus a combined genetic and biochemical approach has proved successful for the analysis 
of yeast splicing factors. 
The isolation of several new temperature sensitive mutations affecting pre-mRNA 
processing has been done (Vijayraghavan, Company and Abelson manuscript submitted). 
Isolation of these eleven new complementation groups affecting pre-mRNA splicing in vivo 
, was done by a direct search for such mutants. Interestingly, several groups (4) with 
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novel phenotypes were obtained, which specifically affect late stages of splicing: cleavage 
at the 3' splice site and exon ligation, and degradation of the lariat intron. These mutants 
facilitate the development of assays for specific steps in splicing, and therefore the analysis 
and purification of specific splicing factors. The isolation of two complementation groups 
(prp17 and prp18 ) with the phenotype of lariat intermediate accumulation allows an op-
portunity for the analysis of splicing components required for the second reaction of splic-
ing. In these mutants the lariat accumulation results from a specific defect affecting the 
second reaction of splicing, as no pre-mRNA is observed in these strains. Fractionation of 
wild type yeast splicing extracts has identified one fraction needed specifically for the sec-
ond step of splicing (Cheng and Abelson 1986). Studies on the prp2 heat inactivated 
spliceosomes have proposed the requirement for a second set of factors in the second 
splicing reaction (Lin eta/., 1987). The need for factors involved only in cleavage at the 3' 
splice site and exon ligation has also been evident in mammalian splicing systems. At least 
two factors have been reported to be required at this stage of splicing in higher eukaryotic 
splicing systems (Krainer and Maniatis 1985; Kraemer eta/., 1987). 
A combination of biochemical and molecular analysis has been initiated for study of 
the role of PRP 18 in splicing. We report that a mutation in one of the previously hypothe-
sized yeast splicing factors results in lariat intermediate accumulation. A specific require-
ment for A TP in the second step of splicing is also observed. The isolation of this novel 
mutation as temperature sensitive lethal, allowed the cloning of the wild type PRP 18 locus. 
RESULTS 
Heat inactivation of splicing extracts from prp18 
The isolation of a ts mutation affecting the second step of splicing in vivo provides a 
method for the study of factors required in the late stages of splicing. We have applied the 
in vitro yeast splicing system and the heat inactivation of mutant extracts for the study of 
the role of PRP 18 in splicing. Whole cell splicing extracts capable of in vitro splicing 
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reactions have been prepared from strains bearing the prp18 mutation. Extracts from cells 
grown at permissive temperature were assayed for splicing activity at permissive tempera-
ture in vitro (150C). The splicing activity is comparable to that of wild type extracts. The 
frrst step of splicing seems unaffected; however, the extent of the second reaction of 
splicing in different prp18 extracts is variable (Fig. 1A compares activities in prp18-2 
strains, 503-1a and 503-6c). Hence, the efficiency of cleavage at the 3' splice site and the 
ligation of the exons appears to be affected in whole cell extracts prepared from this mutant 
strain. 
To investigate the function of the P RP 18 gene product, heat inactivation of extracts 
from prp18-2 strain (ts 503-6c) was carried out . Inactivation of extracts was done by 
heating for 15 to 60 min. at 30-320C under conditions described in Materials and Methods. 
The heat inactivated extracts were assayed at permissive temperature (150C for 60 min.). 
In extracts from prp18 , lariat intermediate and exon 1 accumulate and there is a substantial 
decrease in the levels of the mRNA and the lariat intron after 60min. of heat inactivation 
(Fig. 1B). Similar accumulation of lariat intermediate is observed in vivo for chromosomal 
transcripts from the actin, RP51 and RP59, genes after shift to non-permissive conditions 
(Vijayraghavan, Company and Abelson; manuscript submitted). Some decrease in the 
efficiency of the frrst splicing reaction is observed upon prolonged incubation of prp18 
extracts at 30-320C; the cause is not known. However, heat treatment of some wild type 
extracts also causes a reduced efficiency of total splicing activity (Lustig et al., 1986, this 
study data not presented). 
In vitro complementation of inactivated extracts 
Splicing extracts prepared from prp18 strains accumulate lariat intermediate and exonl. 
One possible reason for this effect is denaturation or inactivation of a specific splicing 
component, as a result of temperature sensitivity of the protein or RNA. To substantiate 
this theory, inactivated prp18 extracts were used to complement inactivated extracts from 
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other ts strains. Complete inactivation of extracts from prp5 or prp11 strains was obtained 
with previously described conditions (Lustig et al., 1986). Mixing of inactivated prp18 
extract with inactivated prp5 or inactivated prp11 extract, resulted in restoration of splicing 
activity (Fig. 2, lanes 1 and 2). A combination of ts 503-6c extract with inactivated extracts 
from cells bearing the same prp18 mutation in a different genetic background did not result 
in complementation (Fig. 2, lane 6). Thus, the loss of activity is due, at least in part, to in-
activation of the P RP 18 gene product; the complementation also indicates that some of the 
splicing factors can exchange under these assay conditions. 
The complementation in vitro with prp5 or prp11 inactivated extracts indicated that 
complementation with the P RP 18 wild type gene product should bepossible. To demon-
strate this we have used fractions of wild type extracts, i.e. , Fraction I (40P3) and Frac-
tions II plus ill (40W) obtained by ammonium sulfate precipitation (Cheng and Abelson 
1986). Complementation of prp18 splicing defect is striking with 40P3 (fraction I) (Fig. 
2, lane 3), while 40W does not seem to contain much complementing activity (Fig.2, lane 
5). We also tested whether prp18 inactivated extract could be complemented by micrococ-
cal nuclease-treated wild type extracts. Micrococcal nuclease treatment of wild type extracts 
causes a complete loss of splicing activity (data not shown), as has been previously re-
ported (Cheng and Abelson 1986). Mixing of the treated wild type extract and the inacti-
vated prp18 extract restores splicing activity (Fig. 2, lane 5). Therefore, complementation 
of inactivated prp18 extracts does not require the presence of intact snRNPs, although the 
complementing activity resides in an snRNP-enriched fraction (40P3). 
Isolation of heat inactivated prpl8 spliceosomes and chasing of the inter-
mediates of splicing 
It has been demonstrated by various means that the first step of splicing takes place only 
after the assembly of the spliceosome is complete (Cheng and Abelson 1987; Lin et al., 
1987; Pikielny et al., 1986; Konarska and Sharp 1987). Complementation with inactivated 
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crude extracts provides evidence for exchangeability of specific complementing factors. 
However, these experiments do not address whether exchange of the factors occurs only 
before or after spliceosome assembly. Isolation of prp18 heat inactivated spliceosome will 
allow the testing of the exchangeability of complementing factors after assembly, and the 
determination of whether this isolated complex is an intermediate in splicing. 
Large scale splicing reactions performed with heat inactivated prp18 extract con-
taining pre-mRNA lariat intermediate and exon1, were sedimented through glycerol gradi-
ents; fractions were collected and counted (Fig. 3A). The labeled pre-mRNA across the 
40S and the 30S region of the gradient was monitored on denaturing gels, revealing a peak 
of lariat intermediate, exon1 and pre-mRNA in the 40S region of the gradient. This indi-
cates that the mutant spliceosomes remain intact after inactivation and gradient sedimenta-
tion. Upon addition of inactivated prp5 or prpll extracts, or the ammonium sulfate frac-
tion 40P3 to the spliceosomal complexes in fraction 12, a conversion to products is ob-
served (Fig. 3B , lanes 1, 2, 3 ). No products are formed in the absence of complementing 
extract (Fig. 3B, lane 7). The chasing of the spliceosomal intermediates is not complete, 
implying some inefficiency in complementation after assembly of the spliceosome. Com-
plementation of the inactivated spliceosome has a requirement for A TP, apart from the need 
for the requisite complementing extract (Fig.3B , lane 8). This experiment demonstrates 
the need for A TP in the second step of the splicing reaction. 
The chasing upon addition of complementing fractions could be due to 1) chasing 
of the lariat intermediate and exon1 in the preformed complex or 2) dis-assembly andre-
assembly of splicing components in the spliceosome and the complementing fraction or 3) 
the chasing of the pre-mRNA in this region of the gradient. In all cases where chasing is 
observed, a decrease in the level of lariat intermediate accompanies the appearance of intron 
and mRNA. This supports our belief that chasing of the spliceosomal intermediates takes 
place. The second possibility has been ruled out by the addition of a second transcript 
during chasing reactions that, if spliced, would result in a different sized mRNA. These 
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chasing reactions did not result in any mRNA production from the second transcript (data 
not shown). In addition the above experiment also shows that if pre-mRNA from this re-
gion of the gradient is being chased, it must be a form of assembled spliceosome. We can-
not rule out this possibility. 
As with the complementation, chasing of splicing intermediates is obtained with 
micrococcal nuclease-treated crude extracts or ammonium sulfate fraction 40P3 (Fig. 3B, 
lanes 4 and 5), again suggesting that neither complementation nor chasing requires intact 
snRNPs. The demonstration of the first step of splicing in inactivated prp18 extracts indi-
cates that prp18 function is probably not needed for the formation of spliceosomes but is 
required for the second step of splicing. 
Isolation of PRP18 gene 
Molecular analysis of the locus encoding the PRP 18 gene product is essential for the com-
plete analysis of the role of this gene product in splicing. The tight linkage of the lariat ac-
cumulation phenotype with the ts lethality in the prp18 strains (Vijayraghavan, Company 
and Abelson; manuscript submitted) allows cloning of the wild type gene product. The 
wild type allele of prp18 was cloned on the basis of its ability to complement the ts muta-
tion in the PRP 18 gene. A prp18 strain was transformed with a yeast genomic library con-
structed in a yeast centromere plasmid library, and incubated on selective plates at 23C. 
The resulting URA transformant colonies were replica plated to pre-warmed rich plates 
(YPD) at 370C to select temperature resistant colonies. Yeast plasmids were recovered 
from several of these colonies and transferred to E. coli . The plasmids were propagated in 
E. coli and preliminary restriction mapping indicated that the recombinant plasmids were 
substantially identical. Retransformation of the prp18 strain with these plasmids from the 
yeast library, after propagation in E. coli, reaffirmed that the presence of the clone confers 
temperature resistance. One of these plasmids (pUV18) was used in further experiments. 
Transformation of the yeast vector YCp50 did not confer wild type growth. 
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Strains bearing the plasmid pUV18 were patched on selective plates containing 5-
Floro-orotic acid, to select for the loss of centromere plasmid from the transformants. ura 
colonies obtained by this method were tested for temperature sensitivity, and were found to 
have reverted to ts phenotype. Thus, the presence of the plasmid alone confers a wild type 
phenotype. Transformation of the clone in a ts prp strain other the prp 18 does not result in 
complementation of other mutation. All of these results indicate that the plasmid sup-
presses the prpl8 ts phenotype specifically. 
pUV18 contained a yeast genomic DNA of about 7kb. A restriction map was gen-
erated. To define the limits of the complementing sequence, specific restriction fragments 
of the insert were subcloned into a yeast low copy (CEN) shuttle plasmid (pPHY18). Fig. 
4 shows that while plasmids pUV18-2, pUV18-4 and pUV18-20, when transformed into 
prpl8 are capable of generating URA, temperature resistant colonies and hence comple-
menting the prpl8 mutation; plasmids pUV18-3, pUV18-17, pUV18-18 and pUV18-19 
yield URA colonies that are temperature sensitive. These results imply that the comple-
menting sequence lies in the Bamlll to Nrul region of the initially isolated genomic frag-
ment in pUV18. Subclone pUV18-20 that was capable of complementing the ts pheno-
type was used in a second series of subcloning experiments and several restriction frag-
ments were cloned into the CEN vector pPHY18. These transformation experiments indi-
cated that the Hindiii site interrupts the complementing sequence, but leave unclear if the 
Xhol site lies within or outside the complementing sequence (Fig. 4). The complementing 
fragment (region from BamHI to Nrul) was also cloned into a yeast multicopy vector (2J.l 
i.e. pSEY18) in addition to the low copy vectors used above. The increased expression 
of this genomic fragment on this plasmid again gave complete complementation. Thus, 
complementation works effectively at either single or higher copy number yeast plasmids. 
Complementation of the mutant splicing phenotype 
prpl8 strain accumulates lariat intermediates of splicing in vivo at both permissive and 
non-permissive temperatures with no increase in the levels of pre-mRNA (Vijayraghavan, 
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Company and Abelson; manuscript submitted). Total RNA was prepared from the original 
prp18 strain, the prp18 strains transformed with complementing plasmids (pUV18 and 
pUV18-15), and from the strain transformed with the vector YCp50. The RNA was run 
on formaldehyde agarose gels, blotted to nylon to membrane and probed with a labelled 
fragment of the actin intron. Fig.5A, lanes 7 and 8 show accumulation of lariat intermedi-
ate of actin in the original prp18 strain and in the prp18 strain bearing only the YCp50 vec-
tor (lanes 1 and 2) at both permissive and non-permissive temperatures. No accumulation 
of lariat intermediate takes place in the strain containing the original complementing clone 
pUV18 (lanes 3 and 4) or the subclone pUV18-15 (lanes 5 and 6). Reverse transcription 
experiments using a primer complementary to the RP51 intron were done (Fig. 5b ). These 
experiments also confirm that the levels of lariat intermediate of RP51 A are reduced to the 
wild type levels. 
Cloned DNA maps to the PRP18 locus 
To prove that the complementing clone obtained corresponds to PRP 18 gene and is not an 
extragenic suppressor capable of relieving the prp phenotype, integration of the cloned 
complementing genomic DNA was performed. A complementing fragment (the 5kb RI 
fragment cloned in pUV18-4) was cloned into the yeast integrating plasmid (YIP5). Inte-
gration into the yeast genome was done after linearization of this YIP5 subclone at the 
unique Xhol site in the genomic fragment (Fig 6A). URA colonies were selected for after 
transformation of the linearized DNA into the wild type temperature resistant strain SS330. 
The URA strains were crossed to the temperature sensitive ura, prpl8 strain, and diploids 
were selected for prototrophy. Sporulation of diploids and dissection of spores from two 
diploid clones demonstrated a co-segregation of the TS and URA phenotype and of the ts 
and ura phenotype in several tetrads (fourteen from each diploid). This analysis shows an 
integration of the cloned DNA with the homologous chromosomal PRP 18locus. 
Southern analysis was also performed as a second means of proving homologous 
recombination to the PRP18locus. Genomic DNA preparations were done from the un-
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transformed strains SS330 andprpl8, two SS330 URA integrative transformants, and the 
diploid of integrative transformant crossed to prpl8 . All the genomic DNA preparations 
were digested with the enzyme Sal!. The DNA was then run on agarose gels, and blotted 
and probed with a fragment containing the entire complementing region. Fig. 6A cartoons 
the expected integration event to the PRP 18 locus. As expected the probe detects only one 
Sall fragment (Fig. 6B) in the untransformed parental strains (no Sail in the PRP 18 gene). 
Each integration event brings in one Sal! site from the YIP5 vector sequences. Hence, as a 
result of integration the probe hybridized to two fragments in the haploid URA integrant 
SS330 Ib (Fig.6B, lane 4 ). Three fragments are detected in the SS330 integrative trans-
formant -Ia (Fig.6B, lane 3), an event most likely due to tandem insertion of two copies of 
the cloned DNA. All of the integration, segregation and southern blot analysis is consistent 
with our having cloned the wild type allele of PRP 18 . 
Identification of the PRP18 transcript 
The cloning of the PRP 18 DNA allows its use as a probe in RNA blots, for determination 
of the transcription units on the complementing genomic DNA fragment. This analysis is 
likely to identify the PRP 18 transcript. Total RNA was prepared from wild type cells at 
both 23C and 37C. Selection of poly A+ RNA was done by an oligo-dT cellulose column. 
A formaldehyde agarose gel was run with both total RNA (10 and 20 !J.g) and polyA+ en-
riched RNA (2 !J.g), and blotted to nylon membrane. The use of the Xhol to Hindlll (-1.1 
kb) fragment as a probe on this blot detects two transcripts of- 1.5kb and -2.3 kb in 
length respectively (Fig? A). The Hindlll to BarnHI DNA fragment (-0.7kb), when used as 
a probe, detected two RNAs of -2.3 kb and -1.8 kb (Fig. 7B). The -2.3 kb poly A+ 
RNA therefore spans the Hindlll site, which has been shown by complementation experi-
ments to lie within the complementing region (Fig. 4). These blots make reasonable the 
deduction that the -2.3 kb poly A+ RNA is being transcribed from the RN AlB locus. The 
-1.8 kb and the -1.5kb transcripts derive from flanking genomic sequences. In vitro com-
plementation with micrococcal nuclease-treated extracts and the detection of a poly A+ RNA 
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being transcribed from the PRP 18 locus both indicate that the gene product is a protein 
component of the splicing apparatus. 
DISCUSSION 
Identification of a factor affecting late stages of splicing 
Biochemical fractionation of splicing extracts and analysis of the assembly of the spliceo-
somes has indicated the importance of snRNP and protein factors in splicing (reviewed in 
Sharp 1987; Maniatis and Reed 1987). In the study ofpre-mRNA splicing in yeast a com-
bined genetic and biochemical approach has been taken with the characterization of the 
PRP2-11 gene products (Warner 1987; Vijayraghavan and Abelson 1988). We have re-
cently reported the generation of a bank of temperature sensitive mutations, which was 
screened for defects in pre-rnRNA splicing (Vijayraghavan, Company and Abelson, 
manuscript submitted). One of the complementation groups with a novel splicing pheno-
type displayed an accumulation, in vivo , of the lariat intermediate. This phenotype re-
sulted from a trans-acting defect affecting splicing and thus provided a means for the 
analysis of the components required specifically for the second step of splicing. In this 
paper we have investigated the role of the PRP 18 gene product in vitro and have also ob-
tained some molecular information about the P RP 18 gene. 
Splicing extracts prepared from the mutant strain are defective for the second splic-
ing reaction, and accumulated the lariat intermediate and exon 1. This splicing defect after 
heat inactivation of splicing extracts is the same as the in vivo phenotype after shift to non-
permissive temperature (Vijayraghavan, Company and Abelson, manuscript submitted). 
The loss of activity for the 3' intron-exon cleavage and exon ligation could result from spe-
cific inactivation of a splicing component, or may be explained as a non-specific effect. 
The second possibility has to be considered as some loss of splicing activity is observed 
upon heating of even wild type extracts (Lustig eta/., 1986; this study). However this is 
unlikely on three counts. First, loss of splicing activity in wild type extracts, when ob-
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served, always diminishes total splicing activity due to a decrease in both reactions of 
splicing. Second, the in vitro loss of activity for the second step of splicing, observed in 
prp18 strains, can be complemented with inactivated extracts from different mutant strains 
and also with fractions of wild type extracts. Restoration of activity in these mixing ex-
periments probably results from the exchange of active components from each of the 
inactivated extracts. Third, the cloned PRP 18 gene completely suppresses the prp18 phe-
notype. The results strongly imply that splicing defect in prp18 results from a specific in-
activation of a splicing component. 
Complementation of heat inactivated prp18 extracts indicated that complementation 
could be achieved by addition of wild type fractions containing the PRP 18 gene product. 
Fractionation of wild type extracts using ammonium sulfate precipitation, followed by hep-
arin agarose chromatography, has already identified three fractions (1, II and ill) , neces-
sary for splicing (Cheng and Abelson 1986). Fractions I and II are together capable of as-
sembling spliceosomes and supporting the first step of splicing. Fraction III is required for 
completion of splicing, in the presence of fractions I and II. Complementation of heat in-
activated prpl8 extracts is achieved best with 40P3 (fraction I) and not with 40W (fractions 
II and III). This indicated to us that there exists a requirement for components other those 
present in fraction III for the completion of splicing in the heat inactivated prp18 extracts. 
The strong complementation obtained with 40P3 (fraction I) implied that the complement-
ing component needed for prp18 is enriched in wild type fraction I. 
PRP 18 probably corresponds to one of the as yet unidentified, but previously hy-
pothesized factors cn. Proposal for the existence of cn came from experiments involving 
chasing of prp2 heat inactivated spliceosomes ( Lin eta/., 1987). In these studies chasing 
of heat inactivated prp2 spliceosomes containing only pre-mRNA with 40P3 (fraction I) 
resulted in completion of both splicing reactions, while complementation of prp2 spliceo-
somes with 40W (fractions II and ill) resulted in accumulation of lariat intermediate. These 
experiments indicated that some factor(s) other than those present in fraction III are re-
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quired for the second step of splicing and they were deduced to be enriched in 40P3 
(fraction I). The complementation of heat inactivated prpl8 extract by fraction I implies 
that the mutant function in this case is possibly one of the cn factors. 
Fractionation of HeLa cell extracts has identified splicing factors required for the 
second step of splicing (Krainer and Maniatis 1985). One component (SF3) identified by 
complementation assays was described as a heat sensitive factor present in nuclear extracts. 
In a preliminary fractionation scheme, SF3 co-fractionated with snRNP- containing frac-
tions. The other component required for the second step of splicing (SF4A) was identified 
in fractions depleted in snRNPs. The role of SF3 and SF4A in splicing reactions is similar 
to that of PRP 18 . The fractionation of SF3 and the activity complementing the prpl8 de-
fect, in the preliminary analysis, occurs in snRNP-enriched fractions. It is therefore 
tempting to compare these two factors. Any further analogy must await better experiments, 
using probes designed specifically for this purpose. 
prp18 spliceosomes represent an intermediate in the splicing pathway 
The complementation of heat inactivated prp18 extracts by other inactivated extracts of prp 
strains implies that splicing components can exchange. The formation of the spliceosome 
takes place even after heat inactivation, suggesting that at least some of the PRP 18 func-
tions are dispensable for spliceosome formation. Experiments were designed to test 
whether the lariats in the spliceosome could be chased to products; and thus to determine 
whether these spliceosomes represent intermediates in splicing. Chasing of the intermedi-
ates of splicing is achieved, with some inefficiency, in the presence of complementing fac-
tors. A strict requirement for A TP is observed for chasing. As with complementation, 
chasing is also observed with micrococcal nuclease-treated crude extracts, indicating the 
dispensability of intact snRNPs for complementation. This still does not rule out the fact 
that PRP 18 is a protein component of snRNP(s), or a dissociable part of a multicomponent 
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structure. This component must be exchangeable with the mutant protein even after 
assembly of the spliceosome. 
The experiments with the chasing of the prpl8 spliceosome reafftrrn the need for 
the PRP 18 gene product for the completion of splicing. It is still unclear if prpl8 is easily 
dissociated from the splicing complexes or if it exists as a component of the inactivated 
spliceosomes. The fact that all factors needed for splicing are not present in gradient iso-
lated spliceosomes has been noted in earlier studies. Spliceosomes containing only pre-
mRNA, when isolated from gradients, are incapable of chasing the pre-mRNA without the 
addition of splicing components and ATP (Grabowski eta/., 1985 ). The incomplete na-
ture of spliceosomes obtained from prp2 heat inactivated extracts has also been reported 
(Lin et al., 1987). The incomplete nature of prp2 or prpl8 heat inactivated spliceosomes 
might result from a loss of factors upon heat inactivation and/or gradient sedimentation. 
Multiple roles for A TP in splicing have been observed for the assembly of the 
spliceosome and for the ftrst reaction of splicing (Cheng and Abelson 1987; Lin et al., 
1987; Konarska and Sharp 1987; Pikielny eta/. , 1986). The requirement for ATP in the 
final step of splicing, 3' cleavage and exon ligation has not been defined. We have shown 
a requirement for A TP in the chasing reactions with prpl8 spliceosomes. In addition we 
have found that only chasing of the preassembled complexes takes place. Since the gradi-
ent fractions that contain the intermediates most probably also have assembly intermediates 
with pre-mRNA we cannot exclude the possibility that this assembled pre-mRNA is being 
chased. The correlation between the appearance of mRNA and the decrease in the lariat in-
termediate, supports our belief that the chasing of the intermediates occurs. Recent experi-
ments with HeLa extracts have reported a requirement for ATP for the second reaction of 
splicing (Sawa eta/., 1988). In these experiments the second splicing reaction was selec-
tively inhibited and completion of splicing in such extracts occurred only in the presence of 
A TP and additional nuclear extract. However, the authors do not address the possibility of 
chasing pre-mRNA in the isolated complex to product, or a possible A TP requirement for 
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the re-assembly of components lost during gradient isolation. Our use of the prp18 muta-
tion affecting the second step of the splicing reactions enabled the development of condi-
tions for the inactivation of the second reaction. Chasing experiments with prp18 heat in-
activated spliceosomes have defined a need for A TP and the dispensablity of intact snRNPs 
for complementation. 
Molecular analysis of PRP18 
The temperature sensitivity prp18 mutation has allowed the cloning of the wild type gene 
and these experiments would be essential in the further analysis of the role of PRP 18 in 
splicing. The cloned gene in single or low copy vectors (i.e., CEN vectors; YCp50 and 
pPHY18) is capable of rescuing the temperature sensitive phenotype and the in vivo splic-
ing defect . The cloned DNA has been characterized by restriction mapping and sub-
cloning; a -2.5 kb genomic fragment has been shown to complement both phenotypes. 
This fragment is unique to the yeast haploid genome. The cloned DNA has been shown to 
be genetically linked to the PRP 18locus by integrative transformation, followed by segre-
gation and southern analysis. These studies showed that the cloned DNA is the wild type 
PRP 18 locus and not a suppressor of the ts and splicing phenotype. Transformation of the 
cloned DNA on multicopy vectors does not alter the complementation of phenotypes, and 
hence over-expression of the protein-using yeast vectors would probably not be deleterious 
to the cell. 
A combination of probes spanning -2.5kb of complementing DNA fragment were used 
to identify the P RP 18 transcript. These experiments were necessary as the larger yeast ge-
nomic fragment, when used as probe, hybridized to more than one poly A+ RNA. The 
PRP 18 gene product is most likely encoded by a poly-adenylated transcript of -2.3kb. 
Further molecular characterization of the locus, including sequencing of the PRP 18 gene 
and over-production of the protein for the generation of antibodies are experiments in 
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progress, and these probes should enable further analysis of this newly identified splicing 
factor. 
MATERIALS AND METHODS 
Strains and microbiological techniques 
The yeast strains used in this study are summarized as : wild type EJ101 and SS330, the 
prp5 strain was RL172 and the prpll strain was SPJ11.4, the genotypes of these strains 
are as described in Lustig et al. (1986) and Vijayraghavan, Company and Abelson 
(manuscript submitted) . The prplB-2 strains were obtained after outcrossing ts 503 with 
wild type strain SS330, and were 503-1a MATa, ade2-101 , his3 L\200, ura3-52 , lys 2-
801 and 503-6c MATa, ade2-101, his3L1200, ura3-52, lys2-801. The yeast strains were 
propagated by standard methods on media as described by Sherman et al. (1986). 
Temperature sensitive strains were maintained at 230C, and 370C was used as the non-
permissive temperature. Sporulation, omission and rich media were prepared as in Sher-
man et al. (1986). Yeast transformations were all done by the lithium acetate procedure of 
Ito et al. (1983). Transformants were selected on omission media at 230C and colonies 
were then replica plated to pre-warmed rich plates (YPD) at 370C to test for temperature 
resistance. The YCp50 based Sau3A library of S. cerevisiae genomic DNA was obtained 
from M. Rose and P. Novick. The yeast shuttle vector pPHY18 (CEN, ARS, URA3 
Ampr) and pSEY18 (2m, ARS, URA3, Ampr) used in sub-cloning experiments was 
kindly provided by P. Herman and S. Emr. Selection for the loss of yeast CEN, URA3 
plasmids was done on 5- fluoro-orotic acid plates prepared as described in Boeke et al. 
(1984). The E. coli strain used for cloning and DNA amplification was MC1061 [F-
araD139 L1 (ara ABIOC-leu) 7679 Ll(lac) x74 galU galK rpsL hsr hsm+ ]. 
Nucleic acid manipulations 
Restriction mapping and standard cloning techniques were essentially as in Maniatis et al. 
(1982). Subcloning of restriction fragments from the plasmids was done after isolation of 
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the desired restriction fragment, and of the suitably digested vectors: pPHY18, pSEY18 or 
YIPS, from low melting agarose gels. The plasmids from E. coli cells were analyzed after 
alkali lysis preparation of DNA. Probes, when used, were restriction fragments obtained 
from low melting agarose gels; and were generated with the random primer labeling proce-
dure of Feinberg and Vogelstein (1983). Small scale preparations of yeast genomic DNA 
were done as described in Sherman eta/. (1986). Southern blots were performed as sug-
gested by New England Nuclear. Hybridizations were conducted in conditions similar to 
that in Cheng and Abelson (1987). 
Preparation of total RNA from yeast was done as described in Vijayraghavan, 
Company and Abelson (manuscript submitted) and polyadenylated RNA was purified by 
oligo-dT cellulose affinity chromatography essentially as given in Maniatis et al. (1982). 
The RNA was separated on formaldehyde agarose gels before blotting on a nylon mem-
brane. Primer extension on 20mg of total RNA, with an RP51 oligonucleotide hybridizing 
70 nts downstream of the 5' splice site as a primer, was performed with reverse transcrip-
tase as described in Vijayraghavan, Company and Abelson (manuscript submitted). 
Preparation of splicing extracts 
Extracts were isolated from cells at mid-to-late logarithmic phase grown in YPD at 230C by 
the spheroplast procedure of Lin eta/. (1985). The protein concentration of the extracts 
was approximately 20 mg/ml. Fractions 40P3 and 40W from extracts of wild type EJ101 
cells were provided by Dr. S.-C. Cheng. 
In vitro splicing reactions, heat inactivation and complementation 
Sp-6 actin transcripts were generated using Sp-6 polymerase with UTP at 100~-LM and 
32P-UTP at 2mCi/ml. Heat inactivation of splicing extracts involved use of 7~-Ll of extract 
to which was added 2.2111 of an inactivation cocktail such that inactivation conditions were 
at 2.4 mM MgCl2, 1mM DTT and RNasin 12u. Inactivation was done at 30 to 320C for 
varying periods and time points were taken and kept on ice until completion of the last time 
point, at which time splicing was initiated. Splicing cocktail was added to obtain a final 
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concentration of 2.2 mM ATP, 55mM KP04 and 2.7% PEG, with 5000-10000 cpm 
(-3.3fmol) of labeled actin pre-mRNA. Splicing was carried out at 150C for 30 to 60 
minutes and reaction mixture was phenol extracted and ethanol precipitated. The precipi-
tated RNA was analyzed on denaturing polyacrylamide gels as described by Lin et al. 
(1985). Complementation in vitro was tested by mixing approximately equal amounts of 
individually inactivated extracts before initiation of splicing. Fractions of wild type extract 
were diluted in inactivation cocktail and were then added to inactivated prp18 extracts. 
Glycerol gradient sedimentation of splicing reactions 
50!11 splicing reactions were chilled on ice and diluted with cold gradient buffer (0.1M 
KCl, 2mM MgCl2, 20mM HEPES pH7 .4) such that the density of the sample was lower 
than that of the top of the gradient. The diluted sample was layered carefully on a 15-27% 
glycerol gradient made in 1/2 inch to 2 inch poly allomer tubes. The sedimentation was 
done at 50,000 rpm for about 100 min. at 2 to 40C, in an SW55 rotor. Fractions were 
collected on ice and Cerenkov counts of the fractions determined. Fractions of interest 
were frozen in liquid N2 and stored at -700C. A small aliquot from each fraction across the 
40S region of the gradient was phenol extracted and ethanol precipitated. The samples 
were analyzed on non-denaturing gels, to confirm that the 40S region contained the ex-
pected labeled RNA molecules. 
Chasing reaction of gradient isolated spliceosomes 
Conversion of the lariat intermediate and exonl to products- lariat intron and mRNA was 
termed a chasing reaction. Typically 20111 reactions with 14!11 of the appropriate gradient 
fraction, 1111 of lOx chasing buffer (200 mM KP04 pH 7, llmM MgCl2, 20mM ATP 
14% PEG 8000) and 2111 of complementing extract was incubated at 150C for 60 minutes. 
Fractions of wild type extract when used for complementation were added at half the vol-
ume of other complementing extracts. The reaction products were recovered by phenol-
chloroform extraction and were separated on polyacrylamide gels. 
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FIGURE LEGENDS 
Fig lA. Splicing activity in prp18 and wild type extracts 
Splicing assays were conducted at 150C for 30 or 60 min. as indicated in the figure. Ex-
tracts from two different prp18 strains, ts 503-la and ts 503-6c, and from the wild type 
strain SS330 were assayed. These extracts were used, without any heat inactivation, in 
splicing conditions described in Materials and Methods. The migration position of the lariat 
intermediate (IVS*E2), the lariat intron (IVS*), spliced exons (mRNA) and the exonl (El) 
are indicated in the figure. 
Fig. lB. Heat inactivation of splicing extracts from prpl8 
ts 503-6c extracts were inactivated in conditions described in Materials and Methods for in-
creasing periods of time (0 to 60 min.) at 320C. After inactivation, splicing is initiated 
with the addition of labeled actin pre-mRNA in a cocktail, and splicing is conducted at 
15°C for 60 min. Reaction products are fractionated on denaturing acrylamide gels. The 
RNA species labeled IVS*E2, IVS*, pre-mRNA, mRNA and El are the same as explained 
in panel A. 
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Fig 2. Complementation of heat inactivated prp18 extract. 
prp18 (ts 503-6c) extract, inactivated at 32°C for 70 min., was assayed individually 
(lane7), and in combination with either heat inactivated (D) prp5 extract (lane 1), or prpll 
(lane 2) or in combination with a different inactivated prp18 (ts 503-la) extract (lane 6). 
Combinations of prp18 inactivated extracts and fractions of wild type extract 40P3 (lane 3) 
or 40W (lane 4), or micrococcal nuclease-treated wild type extract (lane 5) were also as-
sayed for complementation. After mixing of extracts, the splicing reactions are initiated 
with the addition of splicing cocktail and incubation at 150C for 60 min. The reaction in-
termediates and products are indicated and described in Fig. 1A. The delta sign (~) signi-
fies heat inactivated extracts. 
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Fig 3A. Chasing of heat inactivated (~) prp18 spliceosomes 
The gradient prome of a 50ml splicing reaction conducted with inactivated prp18 extracts. 
The reaction mixture was sedimented for 100 min. and analyzed as described in Materials 
and Methods. Analysis of the labeled RNA in an aliquot of the gradient fractions (data not 
shown) revealed a peak of lariat intermediate at fraction 12, corresponding to the peak of 
32p labeled RNA in the 40S region of the gradient. 
Fig 3B. Complementation of prp18 (D) spliceosomes. Fraction 12 from the gradient de-
scribed in panel A, was used as the prp18 heat inactivated spliceosome. The chasing of the 
intermediates in the spliceosome was done as described in Materials and Methods. No 
complementing extract was added in lane 7, lane 1 was incubated with inactivated prpll , 
lane 2 with inactivated prp5, lane 3 with fraction 40P3 from wild type extract, lane 4 with 
micrococcal nuclease-treated 40P3, lane 5 with 40W fraction of wild type extract, lane 8 
was incubated with inactivated prpll extract in the absence of ATP in the chasing mix. 
The products of the chasing reaction, lariat intron (IVS*) and the spliced exons (mRNA), 






















































































































































































Fig 4. In vivo complementation analysis with clones and subclones of PRP 18 . 
Restriction map ofpUV18 and complementation phenotype for the subclones with portions 
of the genomic DNA fragment in pUV18. Only restriction sites relevant to the isolation of 
subclones and the generation of hybridization probes are indicated. + indicates ability to 
suppress the temperature sensitive growth defect of prp18, and- incidates inability to con-
fer temperature insensitivity. The wavy line represents YCp50 sequences and the hatched 
box the complementing region. Restriction enzymes: B, Bam Ill; C, Cia I; E, EcoRI; H, 
























































































































































Fig 5A. Complementation of lariat intermediate accumulation phenotype of prp18 
Total RNA (lOmg in each case) prepared from cultures at 230C and 370C was elec-
trophoresed through a 1.2% formaldehyde agarose gel, blotted and crosslinked to Gene-
Screen. The blot was then probed with a labeled fragment of the actin intron. Lanes 1 and 
2 were loaded with RNA from a prp18 strain transformed with the vector YCp50, lanes 3 
and 4 with RNA fromprp18 transformed with the complementing subclone pUV18, lanes 
5 and 6 prpl8 transformed with complementing subclone pUV18-15 and lanes 7 and 8 
with RNA from the untransformed prp18 strain. The position of the actin lariat intermedi-
ate is indicated. 
Fig 5B. Suppression of lariat intermediate phenotype of RP51A 
Reverse transcription was done to map the 5' end of RP51A transcripts. 20mg of total 
RNA was hybridized to a RP51A oligonucleotide complementary to sequences 70nts 
downstream from the 5' splice site. The extension products are separated on 10% 8M urea 
aery lamide gels. RNA from untransformed wild type and prp 18 strains, the prp 18 strain 
transformed with the complementing plasmid pUV18, prp18 strain transformed with the 
subclone pUV18-15, prpl8 strain transformed with a complementing multicopy plasmid 
were used. The last lane contains kinased oligonucleotide markers of sizes 70, 55 and 35 
nts. The strong extension stop seen in ts 503 just above the 70 nts marker corresponds to a 


























































































































































Fig 6A. Integration of the cloned DNA to the homologous choromosomal PRP 181ocus 
Cartoon of the expected integration event. A 5 kb complementing Eco RI fragment (see Fig 
4) subcloned in YIP5 was linearized at the unique Xho I site and transformed in the wild 
type strain SS330. The open box represents the chromosomal locus and the cloned yeast 
DNA is represented by the hatched box. Plasmid sequences are represented by thin solid 
lines and markers in the plasmid as labeled boxes (Ap represents ampicillin resistance, Tc 
represents tetracycline resistance and URA3 is the yeast marker gene). Restriction sites are 
represented by the same notations as in Fig. 4. 
Fig 6B. Southern blot confirming integration event at the cloned genomic locus. DNA 
from wild type, prp18 strain and from two integrants SS330 Ia and Ib was digested with 
Sal I and run on a 1.0% agarose gel, blotted and probed with the 4.5 kb Bamlll to EcoRI 
(see Fig. 4) complementing fragment. 
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Fig 7. Mapping the PRP 18 transcript. 
A restriction map of the complementing fragment containing the PRP 18 gene is represented 
by the open box, and the wavy lines represent vector sequences. Probe A and Probe B 
were used on a northern blot having 2mg of poly A+ RNA (lane 1 and 2); and 10 and 20 
mg of total RNA (lanes 3 and 4) prepared from wild type cells. The sizes of the transcripts 
were determined by probing the blot for known transcripts (STE2 and TCM1 ) and also by 
running DNA markers (1 Hindiil) on the gel. 
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CHAPTER4 
lntron stabilization in the yeast mutant prp26 
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ABSTRACT 
We have recently reported the isolation of a novel splicing mutantprp26 whose phenotype 
is intron accumulation. Further analysis of this mutant phenotype reveals that the intracel-
lular intron exists in a lariat and a circular form lacking nucleotides from the 3' end of the 
lariat. The stabilization of the cellular intron results from its association with a large particle 
having sedimentation properties similar to that of the spliceosome ( -40S). The composi-
tion of this intron-containing particle was analyzed after gradient sedimentation by northern 
analysis for the presence of the intron and snRNAs. A co-sedimentation of spliceosomal 
snRNAs and the intron was observed. Antibodies that precipitate snRNPs: tri-methyl G 
cap and anti-Sm antibodies, immunoprecipitate the intron. Splicing extracts prepared from 
strains bearing this mutation are active for splicing but are defective in vitro in the degrada-
tion of in vitro generated intron. 
INTRODUCTION 
The removal of intervening sequences from the primary transcript occurs by RNA splicing. 
The study of pre-mRNA splicing in in vitro systems has facilitated the understanding of the 
mechanism of pre-mRNA splicing. A two step mechanism of splicing has been established 
(reviewed in Padgett et al., 1986; Green 1986). In the first step cleavage at the 5' splice 
junction occurs with concomitant formation of splicing intermediates- a lariat RNA of in-
tron-exon2 and exonl. The second reaction involves cleavage at the 3' splice site and liga-
tion of the exons occurs. This cleavage ligation reaction releases the intron in a lariat form. 
Although, mechanistically, the splicing scheme is similar to that of the self-splicing 
Groupll introns (Cech 1986), nuclear pre-mRNA splicing depends upon the assembly and 
function of an RNA and protein complex termed the spliceosome (Brody and Abelson 
1985; Grabowski et al., 1985; Frendewey and Keller 1985; Perkins et al., 1986; Bindereif 
and Green 1986). 
16S 
Splicing complexes were first detected upon sedimentation analysis of splicing re-
actions as 40-60S particles. Small nuclear ribonucleoprotein particles (snRNPs) have been 
shown to be essential components for spliceosome formation and function (Steitz eta/., 
1987; Guthrie and Patterson 1988). Purification of gradient isolated spliceosomes by 
affinity chromatography revealed the presence of U2, U4, US and U6 snRNAs 
(Grabowski and Sharp 1986). Identification of assembly intermediates of the spliceosome 
initially by sedimentation analysis and subsequently by non-denaturing gel electrophoresis 
has facilitated the development of an assembly pathway. An A TP-dependent binding of U2 
snRNP is followed by the binding of U4, US and U6 snRNPs (Konarska and Sharp 1986; 
Pikielny and Rosbash 1986). Prior to the first splicing reaction U4 leaves the complexes 
(Cheng and Abelson 1987; Lamond et al., 1988). Hence the splicing intermediates are 
found in a complex of U2, US and U6. Although the U1 snRNP is known to be essential 
for pre-rnRNA splicing, it was not detected on these assembly intermediates. Analysis of 
the kinetic order of binding of snRNPs to the pre-mRNA by affinity chromatography has 
implied an early and A TP independent binding of U1 to the pre-mRNA, which is followed 
by the binding of U2, U4, US and U6 snRNPs (Bindereif and Green 1987; Ruby and 
Abelson 1988). 
The absence in vivo of branched RNA in the cytoplasm and low levels of branched 
RNAs detected in the nucleus imply a rapid degradation of the lariat intron (Wallace and 
Edmonds 1983). A specific enzymatic activity that hydrolyzes 2'-S' phosphodiester bonds 
has been characterized in HeLa cell extracts (Ruskin and Green 198S; Arenas and Hurwitz 
1986). However, in vitro some of the lariat intron is associated with snRNPs in large 
complexes similar to the spliceosome. These complexes are thought to be involved in the 
dis-assembly of the spliceosome (Konarska and Sharp 1987; Lamond eta/., 1987). The 
release of the intron as a particle explains the protection of in vitro generated intron from the 
effective debranchase present in HeLa cell extracts. The mRNA is released from spliceo-
somes and appears to be associated with hnRNP type complexes. 
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Analysis of splicing factors in yeast has the added advantage of the availability of 
temperature sensitive mutations (prp 2 -II ), which define protein components of the splic-
ing machinery (reviewed in Warner 1987; Vijayraghavan and Abelson 1988). In vitro heat 
inactivation of extracts from these strains has implied a direct role for seven of the above 
complementation groups in the pre-mRNA splicing (Lustig et al., 1986). All but one of 
these complementation groups (prp2 ) defines components required early in spliceosome 
assembly (Lin et al., 1987). A recent search of more such mutants has obtained new com-
plementation groups with novel phenotypes affecting late events in splicing. Two groups, 
prp26 and prp27, define gene products required after splicing is completed, as accumula-
tion of only the excised intron is observed (Vijayraghavan et al., manuscript submitted). In 
this paper we have analyzed the biochemical effects of prp26, which causes accumulation 
of high levels of intron. We provide evidence for the stabilization of the intron in a large 
snRNP-containing complex, probably similar to the post splicing complexes observed in 
higher eukaryotic splicing systems. 
RESULTS AND DISCUSSION 
Accumulation of the branched intron 
A novel yeast mutant with a phenotype of excised intron accumulation (prp26 ) was iso-
lated upon screening for mutants in pre-mRNA splicing (Vijayraghavan et al., manuscript 
submitted). This phenotype results from a trans-acting mutation in a single recessive gene. 
Primer extension analysis on the intron had indicated that the precision of 5' cleavage and 
branch site selection were unaffected. However, much less extension product was made 
from a primer hybridizing between the branch and the 5' splice site, than from the primer 
hybridizing downstream of the branch point. This suggested to us that some of the excised 
intron lacks nucleotides 3' to the branch site. In wild type cells no branched intron can be 
detected for at least four yeast transcripts tested. Only upon in vivo overproduction of an 
actin pre-mRNA fragment containing the intron, is the excised actin intron is detectable 
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(Domdey et at., 1984). The excised intron consisted of four distinct forms- two of 
branched molecules and two linear forms of the intron. 
To further characterize further the mutant phenotype in prp26 , we analyzed the in-
tron after fractionation of total RNA from prp26 on 5% acrylamide, 8M urea gels to sepa-
rate different forms of the intron. After electroblotting of the RNA, the membranes were 
probed with actin intron. They revealed the presence of three different forms of the actin 
intron in this mutant strain (Fig 1B). The largest form of the intron migrates at a position 
similar to that of the complete lariat form of the intron. The most abundant form of the in-
tron has the same mobility as the circular form of the intron, which has lost some nu-
cleotides 3' to the branch. A minor species of the intron, corresponding to a linear form, 
again lacking the 3' nucleotides, is also detected. These RNAs were assigned on the basis 
of their mobility and by comparison with published results (Domdey et al., 1984). None 
of these species is detectable in the wild type parental strain. That these forms of the intron 
are normal intermediates in the degradative process of the intron is indicated by the correla-
tion between the forms of the intron seen in this mutant strain and those observed in vivo 
upon overproduction of actin intron containing fragment . The composition of the intra-
cellular intron in prp26 is thus predominantly branched, although the lariat intron itself is 
not the major form of the intron. The presence of the circular intron probably results from 
nucleolytic digestion of the nucleotides 3' to the branch site. The small amount of the linear 
intron observed suggests that the normal degradative pathway functions to some extent in 
prp26. 
Association of the intron in a 40S particle 
The stabilization of the branched intron in the cell where it is normally degraded, suggests 
that it exists in an intracellular complex. One interpretation of the presence of the branched 
RNAs is that the enzymatic debranching function, responsible for degradation of the unique 
2'-5' linkage in these branched molecules (Ruskin and Green 1985; Arenas and Hurwitz 
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1987), is defective in the mutant strain. Alternatively, protection of the released intron be-
cause of a defect in the dis-assembly of the splicing components may be responsible for 
branched intron accumulation. We therefore investigated the possibility that this mutation 
prp26 results in a protection of the intron due to its association with spliceosomal compo-
nents. 
Whole cell extracts prepared fromprp26 were fractionated on glycerol gradients. In 
parallel, deproteinized RNA from the same extract was also sedimented, to provide a con-
trol for the migration of the naked RNA. Another gradient of an in vitro splicing reaction 
with labeled pre-mRNA provided a marker for the position of the 40S spliceosome. The 
gradient fractions obtained from the mutant extract or the naked RNA were individually ex-
tracted and their RNA content analyzed on northern blots. These blots were probed with a 
labeled fragment of the yeast actin intron. A peak of the intracellular lariat intron, the cir-
cular intron and the minor amount of the linear intron co-sedimented in the 40S region of 
the gradient (Fig. 1A ). In fact this intron containing particle sedimented nearly as fast as 
the spliceosome (data not shown). The presence of all forms of the intron in the same re-
gion of the gradient suggested that they may exist in the same complex. In a parallel gradi-
ent of the naked RNA the lariat and circular RNAs sedimented at the top of the gradient 
(Fig. 1B). These results show the intron is contained in a fast sedimenting particle of 38-
40S; the sedimentation coefficient suggests that the intron is retained in a large post-splicing 
particle. 
Sedimentation of in vitro splicing reactions on gradients has demonstrated a co-
sedimentation of the splicing intermediates in 40S spliceosome (Brody and Abelson 1985; 
Grabowski et al., 1985; Frendewey and Keller 1985; Bindereif and Green 1986). The lar-
iat intron is associated with both a large complex slightly lighter than the spliceosome 
(-40S) and in a heterogenous particle of about -20S (Brody and Abelson 1985; Bindereif 
and Green 1986). The mRNA is released as a smaller, more heterogeneous particle of 
about 20S. Analysis of the assembly of higher eukaroytic spliceosomes on non-denaturing 
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gels has also revealed the presence of a large intron- containing complex that most likely 
represents a post-splicing complex (Konarska and Sharp 1987). After gradient isolation 
the large intron-containing complexes have been reported to be insensitive to in vitro enzy-
matic debranching (Bindereif and Green 1986). 
The intron-containing complexes ( -40S) that accumulate in prp26 containing pre-
dominantly branched RNAs suggests increased stability of a post splicing complex. The 
stabilization is therefore unlikely to result from a defective debranchase. The detection of 
mostly branched intron in the mutant strain prp26 , in large complexes, re-enforces the the-
ory that the stabilization of the intron is due to association with spliceosomal snRNPs. 
lntron-containing complex is associated with snRNPs 
Co-sedimentation of snRNAs and intron complex 
The blots of the gradient fractions used to detect the intron-containing particles were probed 
for the spliceosomal snRNAs- U1, U2, U4, U5 and U6 (Fig. 2A, Band C). U6 and U5 
snRNAs co-sedimentation with the peak of intron is evident. The sedimentation of U4 
with the intron is at about 38S. The larger yeast snRNAs U1 and U2 also appear to co-
sediment. However, the analysis of the association of this intron complex with snRNAs 
through co-sedimentation analysis may be artifactual; because co-sedimentation does not 
indicate that they exist in the same particle. In fact, this analysis is influenced by the fact 
that endogenous multi-snRNP complexes have been detected in wild type cells, which be-
have as large complexes (Konarska and Sharp 1987; Cheng and Abelson 1987). 
Immunoprecipitation of intron by anti-3 mG and anti-Sm antibodies 
The association of snRNPs with the intron in prp26 was tested with snRNAJP specific an-
tibodies in immunoprecipitation experiments. One of the antibodies used is directed against 
the 3mo cap of snRNAs and the other antibody tried was the human autoimmune serum, 
anti-Sm, which has been shown to cross react with, and thus precipitate, yeast snRNPs 
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(Riedel eta/., 1986; Siliciano et al., 1987). The anti 3mG or the control pre-immune serum 
bound to protein A-Sepharose beads were incubated with whole cell extracts prepared from 
the parent wild type strain or the mutant prp26 strain. The bound RNAs were released by 
phenol extraction separated on denaturing gels and blotted to nylon membranes. The intron 
RNA was immunoprecipitated from prp26 extract by both the anti_3mG and anti-Sm sera 
(Fig. 3). As expected, because wild type extracts do not contain introns, none are im-
munoprecipitated. Antibodies directed against the PRP4 gene product of yeast specifically 
precipitate U4 and U6 snRNA from yeast extracts (J. Banroques and J. Abelson, 
manuscript in preparation). These antibodies were also used to investigate if PRP4 protein 
is associated with the intron particle, but no precipitation of the intron was observed (data 
not shown). 
The other product of the splicing reactions, mRNA, is not associated with snRNAs 
and is thus not precipitated (Fig. 3) ( Bindereif and Green 1986; Konarska and Sharp 1987; 
Lamond et al., 1987). The absence of the mRNA in the immunoprecipitates implies that 
the precipitation of the intron is probably not due to non-specific binding of RNA to the 
beads or the antibodies. The fact that the immunoprecipitation occurs by specific recogni-
tion of snRNA cap epitope is indicated by the effective precipitation of the snRNAs U5 and 
U4 (Fig. 3) and the U1 and U2 snRNA (data not shown). The anti-Sm antibody used in 
these experiments largely recognizes the yeast U2, and to some extent the U1, snRNA, but 
does not precipitate the U5 and U4 snRNAs (this study; S.-C. Cheng and J . Abelson un-
published data). These experiments together indicated a direct precipitation of cellular intron 
in prp26 , due to its association with snRNPs. 
Immunoprecipitation of large intron-containing complexes from higher eukaryotic 
splicing reactions indicates the presence of Sm determinants in these complexes, while the 
smaller intron complexes are not precipitable (Bindereif and Green 1986). The association 
of U5, U6 and U2 with the excised intron of higher eukaroytic pre-mRNAs has been 
shown by gel electrophoresis (Konarska and Sharp 1987). Our finding that the endoge-
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nous intron complex in prp26 is Sm precipitable also supports the earlier suggestion that 
the Sm determinants protect the branch site during splicing reactions and after splicing they 
partition with the excised intron. These analyses imply that the stabilization of the intron in 
this mutant strain occurs through association in a large post-splicing complex. It is also 
possible that a defective debranchase is a part of this post-splicing complex and the 
dissociation of the complex can take place only after cleavage of the branch nucleotide. 
This is a possibility that has to be reconciled with the fact that the complex that accumulates 
in prp26 seems similar to the in vitro generated intron complex observed in in vitro splicing 
with HeLa extracts, where this complex was insensitive to endogenous, and also to subse-
quently added, debranchase (Bindereif and Green 1986). 
In vitro phenotype of intron accumulation 
The stabilization of the cellular intron appeared to result from association with snRNPs. 
This observation suggested that splicing extracts prepared from the prp26 mutant strain 
might be depleted for splicing activity because of sequestration of the snRNPs in the en-
dogenous intron complex. The effect of this mutation on in vitro splicing was investigated. 
Splicing extracts were prepared from the original mutant isolated prp26 (ts 45) and also 
from a strain obtained by twice outcrossing prp26 with the wild type strain. Splicing as-
says with labeled actin pre-mRNA were conducted at either 1soc (permissive for mutant 
strains) or 230C. The accumulation of intron was observed in extracts from both strains 
(Fig. 4). In extracts from wild type strains most of the generated intron is degraded, and 
the ratio of intron to mRNA is much less than one (Fig. 4). In the mutant extracts this ratio 
is nearly equal to one, due to the stabilization of the intron. The splicing in vitro must im-
ply that the intron complex containing the cellular introns must be unstable with sufficient 
turnover for initiation of subsequent reactions. The same reason probably applies to the 
fact that this mutation is not lethal to the cell. The accumulation of intron in vitro provides a 
means for assay and purification of the wild type gene product through the use of a com-
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plementation assay. Cloning of the wild type allele should be possible by assaying for the 
absence of introns in mutant strains transformed with a yeast genomic library. 
MATERIALS AND METHODS 
Strains : The yeast strains used in this report are the wild type strain SS330- Mat a ade2-
101 ura3-52 his3-Ll200 tyr1 and the prp26 strains -ts 45 Mat a ade2-101 ura3-52 his 3Ll 
200 lys 2-801 and the twice outcrossed strain 5a-3c- Mat a ade2-101 ura3-52 his 3-Ll200 
tyr 1 . The yeast strains were grown at 23C for splicing extract and RNA preparations. 
Splicing extracts and in vitro splicing reactions : Extracts were prepared from all 
strains at mid-late logarithmic growth phase in YPD. The preparation of extract was done 
as detailed in Lin et al. (1985). Splicing reactions were performed in a buffer with 55 mM 
potassium phosphate (pH7), 2.5 mM MgCl2, 2.4% PEG 8000, 2 mM A TP with 5000-
10000 cpm of labeled actin pre-mRNA (-3.3 fmol) with 60% of the splicing extract. 
Splicing was carried out at 15C for 30-60 min. and at 23C for 10-20 min. The reaction 
mixture was extracted and analyzed on denaturing gels as described by Lin et al. (1985). 
Gradient sedimentation of whole cell extracts : 25 Jll of whole cell extract was di-
luted with 50Jll of gradient buffer (0.1 M KCl, 2 mM MgCl2, 20mM Hepes pH7 .4). Total 
cellular RNA (-15 Jlg) when run on the gradient was also diluted in gradient buffer before 
layering on the gradient. 11-23% glycerol gradients were made in 1/2 inch to 2 inch 
polyallomer tubes. The sedimentation was done for 100 min. at 4C at 50,000 rpm. Frac-
tions were collected on ice and the RNA was extracted with twice phenol-chloroform and 
ethanol precipitated. RNA from all fractions was loaded on 5% acrylarnide (29:1), 8M urea 
gels. After electrophoresis, RNA from the gels was transferred to GeneScreen membranes 
(NEN) by electroblotting at 4C for 12-15 hrs at 30V in 25 mM sodium phosphate pH 6.5. 
The RNA was crosslinked as described in Cheng and Abelson (1987) and hybridized with 
the desired probes. 
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Northern blots: Prehybridizations and hybridizations were done similar to the procedure 
in Cheng and Abelson (1987). Probing for actin intron was done with a 
Xhol -Clal fragment of the actin intron labeled by random primer extension (Feinberg and 
Vogelstein 1983). snRNA probes used for U1, U2, U4, U5 and U6 were prepared as de-
scribed in Cheng and Abelson (1987). 
lmmunoprecipitation :Antiserum 3mG, Sm or PRP4 or the pre-immune serum when 
used were coupled to Protein A-sepharose in conditions as given in Cheng and Abelson 
(1986). 10J..ll of either wild type SS330 extract or mutant prp26 extract was added to the 
beads. After incubation at 4C the beads were washed and extracted with phenol-chloro-
form and the RNAs precipitated. The RNAs were then fractionated on 5%, 8M urea gels 
and electroblotted on membranes, the RNA crosslinked and probed for actin transcripts and 
snRNAs. 
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FIGURE LEGENDS 
Fi. 1 Association of cellular excised intron with -40S complexes 
Fig lA. Gradient sedimentation of whole cell extracts fromprp26 
Fig lB. Gradient sedimentation of deproteinized RNA from prp26 
Individual fractions from both gradients were collected on ice, and the RNA was ex-
tracted and fractionated on denaturing acrylamide gels. Electroblotting was followed by 
probing both blots for actin intron as described in Materials and Methods. Arrows indicate 
the position and form of the three endogenous actin intron types detected. The blot in panel 
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Fig 2 Analysis of snRNP sedimentation in extracts from prp26 
Fig 2A. Reprobing of blot in Fig. 1 panel A, with yeast U1 and U2 snRNA probes. 
These probes were prepared and hybridized as described in the text. 
Fig 2B. Detection of U5 and U4 particles in extracts of prp26 after reprobing of blot in 
Fig 1. panel A. 
Fig 2C. Repro bing blot of intron-containing complex with a kinased oligonucleotide com-
plementary to U6 snRNA detects U6 snRNP in prp26 extracts. 
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Fig 3. Immunoprecipitation of cellular intron from prp26 with snRNA/P specific antibod-
ies 
Splicing extract from wild type or from the mutant prp26 was incubated with preimmune 
(lanes 1 and 2), anti 3mG(lanes 3 and 4) and anti-Sm (lanes 5 and 6) as indicated. RNA 
was extracted from the immune complexes and fractionated on denaturing gels and elec-
troblotted. The blot was probed with a fragment of the actin gene, to detect intron and ma-
ture mRNA, and with U5 and U4 snRNA probes to monitor the immunoprecipitation with 
anti3mG antibody. Deproteinized RNA from the mutant strain (lane 7) and wild type strain 
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Fi. 4. In vitro splicing reactions with prp26 or wild type extract. 
Splicing reactions with prp26 extracts or wild type SS330 extracts were performed as de-
scribed in Materials and Methods. Extracts were prepared from two mutant strains, an 
original isolate of prp26 - ts 45 and also from a strain obtained after two outcrosses prp26-
5A-3C. The temperature and the time of incubation for the splicing reactions are indicated 
in the figure. The position of lariat intermediate (IVS*E2), lariat intron (IVS*), precursor 
(pre-mRNA), spliced product (mRNA) and exonl (El) are also indicated. 
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